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The ERK/MAPK pathway is a ubiquitous serine/threonine kinase cascade that 
directs growth, differentiation and plasticity in various tissues.  Transmembrane receptor 
proteins acts as a bridge between extracellular signals and the ERK/MAPK pathway, so  
regulation of these receptors is of crucial importance towards maintaining a healthy cell.  
Many regulatory mechanisms exist, all of which make use of protein interaction domains 
to bind to their substrates. This thesis draws examples from two regulatory proteins, c-
Cbl and calmodulin. 
c-Cbl is an E2 ubiquitin ligase and a major regulator of tyrosine kinases at the 
membrane.  Through x-ray crystallography of five Cbl-TKB: phosphopeptide complexes, 
our work demonstrate the mechanism by which the Cbl-TKB domain binds to its 
substrates through a conserved, specificity determining intrapeptidyl hydrogen bond. The 
ability of Cbl to bind to its substrates in a reverse orientation given the TKB atypical 
binding motif found in the Met family of proteins was also uncovered.  This finding 
implicates that there may be a group of yet undiscovered Cbl substrates. 
Calmodulin is a calcium binding protein that modify its substrates’ activity by 
conferring calcium sensitivity when it binds with its substrates.  One of the domains 
responsible for this interaction is the IQ motif.  All voltage gated sodium channels 
possess this motif but bind differentially to calmodulin.  Through biophysical and 
computational analyses, we characterised the way calmodulin binds to two high affinity 
sodium channel isoforms Nav1.4 and Nav1.6.  Together with mutation of two residues 
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1.1 General Introduction 
 In order to survive and adapt, every organism must be able to accurately respond to 
spatial and temporal cues.  In unicellular organisms, the response to these cues can be rapidly 
transduced within the cell to achieve the desired change.  However in multicellular organisms 
where billions of cells are organised into specific tissues and organs, transport of cues required to 
effect a change within tissues becomes more complex.  Cells respond to these cues through 
numerous molecules such as proteins, peptides, lipids and inorganic molecules linked via 
intricate intracellular networks that efficiently transport these external signals across the plasma 
membrane into the cytosol and nucleus of the desired cell, where the effects occur.  This process 
of transporting an external signal within the cell to induce a desired outcome is termed signal 
transduction or cell signalling. Certain conserved signalling pathways are reiteratively employed 
in biological systems to propagate, regulate, integrate and evoke tissue-specific responses.  At 
the heart of these, protein-protein interactions form the basis through which signals are 
selectively modulated to determine a cell’s fate.   
 
1.2 Signal sensing 
Cell to cell communication is essential to ensure that responses to external signals are 
appropriately coordinated.  Cells signal to each other in several ways, depending on the distance 
between the signalling cell and the target cell.  Not all molecules can be trafficked across the 
lipid bilayer: cells therefore relay messages via a cascade of intracellular events that is tightly 
regulated at key steps where pathways converge.  All signal transduction pathways that are 
initiated by a non-permeable extracellular stimulus are received by a cell surface receptor, often 
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a transmembrane protein which causes a conformational change in the receptor upon sensing the 
stimulus.  If the cells are touching, signalling may be through pores in the membrane, such as 
gap junctions or plasmodesmata, or due to a membrane bound ligand being identified by a 
receptor in the membrane of a neighbouring cell (Fig. 1.1b and c).  If the cells are further apart, 
they may communicate via the release of molecules (Fig. 1.1a) in the form of cytokines, 
chemical agonists, growth factors and ions which are detected by the target cell via endocrine, 
paracrine, autocrine or synaptic signalling. 
 
Fig. 1.1.  Different ways cells signal to each other (Adapted from Hancock, 2005). (a) Communication to a distantly 
located cell through the release of signalling molecules into the extracellular space which travel to the target cell. (b) 
Crosstalk between neighbouring cells via gap junctions through which molecules can pass.  (c) Signalling through a 
membrane bound ligand that is detected by a receptor on the neighbouring cell. 
  
Synaptic: A fast and efficient method of signalling over the length of an axon via changes in the 
electrical potential across the membrane of a cell.   
Endocrine: Cells release signalling molecules, such as hormones, that travel vast distances 




Paracrine: Cells release signalling molecules that diffuse and are detected by adjacent cells. The 
signal is often quickly terminated by endocytosis, degradation or immobilisation.  
Autocrine: Similar to paracrine signalling, where the signalling molecules act upon the cell that 
released them.  This type of signalling is often found in differentiating cells as reinforcement 
towards a committed cell fate. 
 
1.3 Types of receptors 
 Extracellular molecular signals are usually found at low concentrations (~10-8mol/L).  
Detection of a signal is usually accomplished by specific receptors on the cell surface that have 
high binding affinity in the concentration range of the ligand.  Binding of the ligand will then 
stimulate the required intracellular response via a signal transduction pathway.  Despite the vast 
array of extracellular molecules that need to be detected by a single cell, receptors fall into four 
main classes: ion channel linked, G-protein linked, those containing intrinsic enzymatic activity 
(e.g., receptor tyrosine kinases - RTKs) and receptors without enzymatic activity but associate 
with cytosolic enzymes (e.g. non-receptor tyrosine kinase - NRTKs) (Fig. 1.2).  Accordingly, 
they each initiate a series of distinct intracellular enzymatic activities in sequential order, to be 
known as signal transduction pathways that eventually result in changes to gene expression 





Fig. 1.2.  Different receptor classes in an organism (Adapted from Hancock, 2005).  (a) Ion channel receptors that 
open to allow the free passage of ions across the membrane upon stimulation. (b) Receptors linked to G-proteins.  
Dissociation of the G-protein from the receptor upon stimulation initiates a cascade of signalling events.  (c) 
Receptors with enzymatic activities are activated through binding of their cognate ligands.  (d) Intracellular 
receptors are not membrane bound but may be linked to receptors without any enzymatic activity.  They affect 
signals similar those from receptors with innate enzymatic activity and are mainly involved in immune responses. 
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1.3.1 Example 1: Receptors with tyrosine kinase activity 
Of the 32000 coding genes in the human genome, approximately 20% of these encode for 
proteins involved in signal transduction - more than 520 are protein kinases and 130 are 
phosphatases.  Signal transduction pathways make extensive use of phosphorylated proteins 
(phosphoproteins) in which serine, threonine and tyrosine (pTyr) are the residues most 
commonly phosphorylated.  Protein tyrosine kinases (PTKs) transfer the γ phosphate of ATP to 
the hydroxyl group of a tyrosine in a protein substrate.  The 90 known PTK genes are distributed 
into two pools, 58 encoding receptor tyrosine kinases (RTKs) and 30 encoding non-receptor 
tyrosine kinases (NRTKs).  
 
Receptor tyrosine kinases 
RTKs are transmembrane glycoproteins activated by the binding of their cognate ligands 
that transduce extracellular signals to the cytoplasm to stimulate changes within the cell.  This is 
accomplished by phosphorylating tyrosine residues on themselves (autophosphorylation) and on 
downstream adaptor proteins upon ligand binding.  The RTK family includes the receptors for 
insulin and for many growth factors, such as epidermal growth factor (EGFR), fibroblast growth 
factor (FGFR), platelet-derived growth factor (PDGFR), vascular endothelial growth factor 




Fig. 1.3.  Domain architecture of different RTK families (Hubbard and Till, 2000).  RTK family members of the 
same structural organization are indicated under each module.  The portion above the black horizontal lines 
represents extracellular domains involved in ligand binding, and tyrosine kinase domains are exclusively found in 
the intracellular region.  The Met (Met, Ron, Sea) and insulin receptor (InsR, IGF1R, IRR) family members 
comprise of multiple subunits within a single receptor, hence the discontinuous extracellular domains. 
 
With the exception of Met, the insulin receptor and their respective family members, 
RTKs exist as a single polypeptide chain that dimerize upon stimulation.  The extracellular 
portion of RTKs contain a varied array of globular domains that are used for ligand binding.  The 
domain organization in the cytoplasmic portion of RTKs consists of a juxtamembrane region 
after the transmembrane helix followed by the tyrosine kinase catalytic domain and a carboxy-
terminal region (Fig. 1.3).  All RTKs possess between one to three critical tyrosine residues in 
the kinase activation loop (Hanks et al., 1991).  With the exception of EGFR, phosphorylation of 
these residues seems to be essential for the activation of its catalytic activity.  The 
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juxtamembrane and C-terminal regions are varied in length, and may also contain tyrosine 
residues that are autophosphorylated upon ligand binding. 
 
Non-receptor tyrosine kinases 
In addition to the RTKs, there exists a large family of non-receptor tyrosine kinases 
(NRTKs), including Src, Spleen tyrosine kinase (Syk) / ξ-chain associated protein kinase 70kDa 
(ZAP-70) and Abelson murine leukemia tyrosine kinase (Abl) among others.  These proteins 
exist in the cytosol as soluble components, or may be receptor associated.  The Src subfamily of 
proteins is the largest of all NRTKs, with nine members and implications in many human 
carcinomas. NRTKs are integral components of signal cascades from receptors with no intrinsic 
tyrosine kinase activity by binding to and triggering responses that are similar to RTKs 
(Gomperts et al., 2003).   The receptors they associate with typically mediate immune and 
inflammatory responses in leucocytes and lymphocytes.  In addition, certain NRTKs like c-Src 
modify specific signals by acting on proteins that are part of the pathway, or proteins that 
regulate the pathway (Luttrell et al., 1996).  
As with RTKs, NRTKs are activated when the activation loop tyrosines are 
phosphorylated.  Phosphorylation can occur in-trans or by a different NRTK.  In addition to a 
tyrosine kinase domain, NRTKs possess domains that mediate protein-protein, protein-lipid, and 
protein-DNA interactions (Fig. 1.4). The most common protein-protein interaction domains in 





Fig. 1.4.  Domain architecture of different NRTK families (Hubbard and Till, 2000).  Each NRTK family has the 
same structural organization and is indicated to the left of each module.  Besides the conserved tyrosine kinase 
domain, other domains mainly for protein-protein interactions are also found in each protein. 
 
1.3.2 Example 2: Ion channel receptors 
 The human brain consists of approximately 20 billion neurons, with an average of 7500 
synaspes per neuron (Pakkenberg et al., 2003; Pakkenberg et al., 1997).  At every synaptic 
interface, chemical signals are transmitted from the axon of the effector cell to the dendrites of 
the receiving cell.  These extracellular chemical signals released and sensed by neurons are 
collectively known as neurotransmitters, and serve to convert and relay electrical signals in the 
form of chemical messengers across the space between two communicating neurons.   
There are two types of neurotransmitter receptors – those that are able to form ion 
channel pores (ionotropic), and those that are G-protein coupled receptors (metabotropic). When 
captured by receptors on the receiving dendrite, neurotransmitter ligands initiate depolarisation 
of the cell either through the opening of an innate channel in ionotropic receptors, or through 
signal transduction mechanisms via G-proteins linking to ion channels. 
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Within each neuron, transmembrane ion pumps and receptor channels maintain a resting 
potential of -70mV by transporting sodium ions out of the cell and potassium ions into the cell 
against a concentration gradient.  Neurotransmitter activation initiates the opening of sodium and 
calcium receptors through conformational changes.  If this event causes a depolarization beyond 
a threshold of -60mV, positive feedback causes further depolarization to +40mV through the 
opening of more voltage-gated sodium channels (VGSC), followed by the efflux of potassium 
ions when its channel opens later.  After this electrical impulse called the action potential has 
passed, the ion channels rapidly close and sodium and potassium pumps return the cell 
membrane to its resting potential (Fig. 1.5).  During this time, ion channels undergo an 
inactivation period during a refractory stage when they cannot be stimulated or require a larger 
stimulus to be activated.  This process is known as the action potential, and is essential in all 
nervous signal transduction. 
 
Fig. 1.5.  The action potential during nervous transmission (Adapted from mindcreators.com; Cofer, 2002).  The 
axes represent change in membrane potential against time in millisecond.  The cell is normally kept at -70mV in 
resting state with high concentration of K+ and low Na+ inside the cell against a concentration gradient.  An initial 
11 
 
10mV depolarization is the threshold required to initiate an action potential in which the sodium channels first open 
to allow an influx of Na+ ions (1).  Potassium channels later open (2) allowing the efflux of K+ to hyperpolarize the 
cell.  At the end of the action potential, K+ channels close (3) and ion pumps revert the Na+/K+ concentrations back 
to its resting state in preparation for another wave of excitation.  
 
 Ion channel receptors are classified according to ligand specificities.  All are assembled 
from subunits of homologous polypeptides that arise from alternative splicing and arranged in a 
ring structure with a water filled channel running perpendicular to the plasma membrane.  The 
cytoplasmic extension of the channel may contain stretches of amino acids for interacting with 
other proteins. 
 
1.4 Mitogen-activated protein kinase pathways 
 Among the pathways used to transduce a signal is the highly conserved mitogen-activated 
protein kinase (MAPK) pathway.  This pathway was initially found to be activated by mitogens, 
and a critical regulator of cell division and differentiation.  Subsequent studies have shown it to 
be also inducible by physical and chemical stressors such as UV irradiation, heat and osmotic 
shock.  The MAPK pathway is the prototypic signalling cascade found in all eukaryotic 
organisms and in its most basic form, consists of the sequential phosphorylation and activation of 
at least three protein kinases, MAPKKK, MAPKK and MAPK.   
Mitogen-activated protein (MAP) kinase kinase kinases (MAPKKK), also known as 
MAP3K or MEKK, integrate multiple inputs which, in turn, phosphorylate MAP kinase kinases 
(denoted MAPKK, MAP2K, MKK or MEK).  MAPKK enzymes are dual-specificity enzymes 
with limited substrate specificity, belonging to the MAP/ERK (MEK or MKK) family of kinases.  
Although activated by multiple MAPKKKs, MAPKKs only phosphorylates serine/threonine 
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(Ser/Thr) and Tyr residues on one or a few MAP kinase (MAPK) proteins (Kosako et al., 1992).  
Phosphorylated MAPKs are known to control almost all cellular processes ranging from gene 
expression to cell death (Chang and Karin, 2001) by migrating to the nucleus to recognise 
transcription factors with the motif (S/T)P, PX(S/T) or (S/T)G (Lewis et al., 1998).  In mammals, 
this pathway can be sub-divided into at least four distinct groups – ERK/MAPK, JNK/SAPK, 
p38 and ERK5 pathways – according to the specific MAPK activated (Fig. 1.6). 
 
 
Fig. 1.6.  The different classes MAPK signalling pathways in humans (ERK/MAPK, p38 and JNK/SAPK and 
ERK5).   MAPKKK (MAP kinase kinase kinases) are represented as yellow boxes, MAPKK (MAP kinase kinases) 




1.4.1 Classical ERK/MAPK pathway 
The MAPK/ERK pathway (Fig. 1.5) is induced by ligands received by specific RTKs; 
and, upon binding to their respective growth factors, oligomerize and autophosphorylate tyrosine 
residues in trans.  These phosphorylated tyrosines signal the recruitment of adaptor proteins such 
as Grb2. Guanine nucleotide exchange factor Son of Sevenless (SOS) translocates to the 
membrane, associates with Grb2 and relays the signal by catalysing the activation of Ras by 
exchanging GDP to GTP.  Ras-GTP activates Raf-1, a ubiquitous MAPKKK, by binding to and 
relieving its inhibition by the N-terminal regulatory domain (Yip-Schnider et al., 2000).  Raf-1 
regulation is complex, involving several kinases and phosphatases (Avruch et al., 2001; Jelinek 
et al., 1996; Warne et al., 1993; Moodie et al., 1993, Pearson et al., 2001; von Kriegsheim et al., 
2006; Jaumot and Hancock, 2001).  Once activated, Raf-1 dually phosphorylates either serine or 
threonine in the activation loop of MAPKKs MEK1 and MEK2.    
The extracellular signal-regulated kinases (ERK) are the most common and best 
characterised serine/threonine protein kinaes that are activated downstream of the ERK/MAPK 
cascades.  Occuring in two closely related isoforms ERK1/p44 and ERK2/p42, they are possibly 
unique substrates to MEK1/2.  Although ubiquitously expressed, their relative expression levels 
vary between tissues and they are predominantly associated with positive cellular responses such 
as proliferation, differentiation, migration and tissue growth.  One of the most explored functions 
of MAPK signalling modules is the regulation of gene expression in response to extracellular 
stimuli.  While the primary site of MAPK action, such as ERKs, is inside the nucleus to 
phosphorylate transcription factors prebound to DNA, much remains in the cytoplasm to regulate 
gene expression through post transcriptional means such as mRNA stabilisation (Chen et al., 
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2000; Winzen et al., 1999; Lasa et al., 2000) and translational control (Kotlyarov et al., 1999; 
Pyronnet et al., 1999).  
 
1.4.2  An adaptation of the ERK/MAPK pathway: Synaptic plasticity  
There are two forms of memory: short-term working memory, and long-term memory.  
Memory serves a basic purpose to increase an organism’s survivability by recognizing food, 
danger, prospective mates and environmental cues.  Organisms have thus developed a 
complicated yet reliable system of constant addition, expansion, alteration and eradication of 
memories to better serve their interests. 
Memories are formed in the hippocampus and amygdala of the brain where the binding of 
glutamate to N-methyl-D-aspartate receptor (NMDAR) causes both the influx of calcium 
through opening of the ion channels and activation of calcium-dependent kinases that lasts 
between 60 to 90 minutes (Sweatt, 2001).  At the same time, calcium channel, α-amino-3-
hydroxy-5-methylisoxazole-4-proprionate receptor (AMPAR) increases in number at the 
synapse, is phosphorylated and generates a greater influx of calcium.  This phenomenon 
reinforces the synaptic connections between the effector and effected neurons and is known as 
long term potentiation (LTP), more specifically the early phase of LTP.  LTP is the long lasting 
communication improvement between two neurons that results from stimulating them 
simultaneously, while synaptic plasticity is the ability of two neurons to establish this 
connection.  The LTP theory is a signalling model for memory formation, and the early phase of 




1.4.3 ERK/MAPK pathway in late LTP 
Maintaining LTP in activated neurons is essential for the formation of long-term 
memory.  Following NMDAR activation, a cascade of kinase activities ensue that ultimately 
changes gene expression levels in the late phase of LTP.  If this is not sustained, short-term 
memory formed during early LTP will be erased.  During late LTP, the classical ERK/MAPK 
pathway of Ras/Raf, MEK and ERK integrates signals from neurotransmitter receptors, Src and 
Ca2+ (English and Sweatt, 1997; Gottschalk et al., 1999; Boxall and Lancaster, 1998; Thomas 
and Brugge, 1997) (Fig. 1.7).  ERK2 is essential in memory consolidation by phosphorylating 
calcium and cAMP response element binding transcription factor, enabling transcription of its 
genes (Cestari et al., 2006).  Activated ERK also phosphorylates the voltage-gated potassium 
channel (Schrader et al., 2006); tyrosine phosphorylation of NMDAR or associated proteins also 
lead to increased channel activity and influx of calcium ions, which in turn strengthen AMPA 
mediated synaptic transmission (Purcell and Carew, 2003). 
Increased post synaptic receptor activity as a result of heightened cell sensitivity towards 
signals during learning of is important for enhancing communication between neurons (Bliss and 
Lomo, 1973; Anderson et al., 1980).  This is attributed in part to the increased sensitivity of the 
voltage-gated sodium channel (VGSC) to membrane depolarization through a progressive 
decrease in action potential threshold.  Together with an increased input resistance due to a 
hyperpolarized shift in slow inactivation curve of VGSC, the excitability of postsynaptic neurons 
is enhanced (Xu et al., 2005).  This change in activation kinetics of the VGSC was found to be 





Fig. 1.7.  The role of CaM in a simplified ERK/MAPK pathway during neuronal LTP for the formation of memories 
(Xia and Storm, 2005).  CaM acts as a Ca2+ sensor to modulate the function of various proteins in different 
concentrations of Ca2+, caused by neurotransmitter ligands that initiate the opening of NMDA and AMPA receptors 
to allow an influx of Ca2+. 
  
 
1.5 Regulating signal transduction pathways at the receptor level 
To create varying cellular responses, cells manipulate the same signalling pathways by 
altering the amplitude, duration and location of its activation.  Consequently, several 
mechanisms exist to ensure that the appropriate signal thresholds are achieved and maintained 
for the correct length of time or aptly attenuated for strict regulation of receptor activity. This 
need for tight regulation of catalytic activity is underscored by the numerous diseased states that 
result from deregulated pathways.  Controlled signalling within the cell is predominantly 
achieved by inbuilt on/off switches and negative feedback mechanisms.  Diverse classes of 
molecules have evolved for this function, ranging from enzymes to inorganic factors.  Those 
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mechanisms that do not degrade a pool of proteins are deemed as transient - their targets can be 
re-activated once inhibition is lifted.  On the other hand, the most common mechanism to 
permanently attenuate a signal is through protein internalization and degradation.  
 
1.5.1 The role of regulatory ligands and proteins in modulating receptor activity 
Just as the essential components of signal transduction pathways have evolved methods 
to enhance and efficiently propagate a signal, many other proteins exist to control amplitude, 
duration and location of pathway factors.  Known as regulatory proteins, these proteins are key 
determinants of specific cellular outcomes, and although critical to the fate of an organism, they 
are not essential for the initiation and propagation of signal.   
Regulatory mechanisms often engage competitive inhibitory oligomerization with ligands 
or other proteins to carry out their function.  For example, the Tie2 receptor whose signal is 
initiated by angiopoietins binding has a natural inhibitory ligand that prevents further activation 
of the receptor (Maisonpierre et al., 1997).  Certain tissues purposefully express receptor variants 
deficient in tyrosine kinase activity for dominant negative inhibition through the generation of 
inactive heterodimers.  In other cases, PTKs require association with other proteins or 
homodimerization to become functional.  For example, engagement of Syk with the tyrosine-
phosphorylated ζ-chain of the T-cell receptor relieves inhibiton on the kinase domain and 
stimulates its catalytic activity (Shiue et al., 1995).   
An activated receptor usually induces positive and negative pathways simultaneously that 
are functionally connected by numerous feedback mechanisms.  For example, the EGF receptor 
in Drosophila mediates the expression of Spitz and Argos, positive and negative auto-regulators 
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of the EGF induced MAPK pathway respectively (Wasserman and Matthew, 1998) to define 
body axes and patterning in developing oocytes.  Src, when in its activated state, phosphorylates 
a conserved tyrosine in the N-terminal of Sprouty proteins.  This phosphorylated tyrosine residue 
can bind and sequester Grb2, impairing the recruitment of SOS to RTKs (Gross et al., 2001).  
The precise mechanism of Sprouty proteins in the MAPK signalling however, has yet to be fully 
elucidated  
 
Example: Sprouty proteins regulating receptors with tyrosine kinase activities  
Sprouty was first discovered in Drosophila as a 63kDa protein that inhibited fibroblast 
growth factor (FGF) receptor signalling (Hacohen et al., 1999) in tracheal branching.  
Subsequent studies revealed that there were four human Sprouty homologues, all considerably 
smaller than Drosophila’s possessing two conserved sequences – a highy homologous Cys rich 
C-terminus, and a short stretch in the N-terminus centred around a phosphorylated Tyr (pTyr).  
Sprouty has no intrinsic enzymatic activity of its own, but its expression pattern during 
embryonic development synchronises with known sites of RTK signalling and localises to the 
membrane through the Cys rich C-terminus (Kim and Bar-Sagi, 2004).  Prturbation of the RTK 
signalling that result from the expression of Sprouty proteins produces a broad spectrum of 
effects that range from alterations to developmental fate and changes in cellular homeostasis 
(Kim and Bar-Sagi, 2004). 
 Upon receptor stimulation, the essential tyrosine within the SH2-like binding motif of 
Sprouty becomes tyrosine phosphorylated.  This phosphorylation event has been linked to the 
ability of Sprouty to downregulate ERK phosphorylation.  Combined evidence points to two 
areas of action within the ERK/MAPK pathway: upstream of Ras and upstream of Raf-1 
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(Hanafusa et al., 2002; Lao et al., 2006).  Under normal circumstances, EGF signalling triggers a 
negative regulatory response to downregulate the receptor from the cell-surface via c-Cbl 
mediated ubquitination.  Sprouty through its binding to the conserved tyrosine in the N-terminus, 
competes with EGFR for binding to Cbl, and prevents it from interacting with, and thus 
downregulating the EGFR (Fong et al., 2003).   
 
1.5.2 The role of function-modifying proteins in regulating receptor activity 
Besides down-regulation, there are also certain proteins whose nature is to modify the 
function of their binding partners.  The ubiquitous 14-3-3 protein isoforms are probably one of 
the best characterized as effecting both positive and negative regulation.  In the ERK/MAPK 
pathway, Ras activity is upregulated by its binding with the catalytic domain of 14-3-3 proteins, 
but suppressed through association with the regulatory domain (Yaffe, 2002).  Other proteins 
possessing such modulatory roles include the Regulator of G-protein signaling (RGS) protein, 
primarily to enhance the GTPase activity of an activated G-protein, and calcium binding proteins 
S100 and calmodulin (CaM) that the ability to be regulated by intracellular Ca2+. 
 
Example: Calmodulin regulation of ion channel receptor activity 
Various stimuli, such as changes in membrane polarization or small receptor ligands may 
trigger the opening of calcium channels, resulting in the influx of Ca2+ ions into the cytosol.  
Many forms of synaptic plasticity are initiated by an increase in intracellular calcium ions (Ca2+) 
which functions as a second messenger for activity dependent, synapse specific changes.  The 
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approximately 100-fold increase in free Ca2+ concentration during synaptic transmission from 
NMDAR and AMPAR allows Ca2+-binding proteins to trigger response mechanisms that are 
able to integrate and transmit this signal coherently to downstream processes.  
The key Ca2+ regulator protein in the brain is calmodulin (CaM), a 16.8kDa highly 
conserved ubiquitous protein whose sequence is identical among vertebrates.  Many proteins, 
including ion channel receptors, alter their activity in response to changes in free Ca2+ levels, but 
are not able to bind Ca2+ ions by themselves.  CaM, when bound to several ion channels crucial 
for synaptic plasticity, confers Ca2+ sensitivity to its binding partners through a conformational 
change (Fig 1.8).  CaM’s regulatory role in mediating the Ca2+ signal is highly localized and so 
entrenched in regulating ion channel receptors’ functions that it has been suggested to to be 
classified as a channel subunit (Saimi and Kung, 2002).  The importance of CaM is reflected in 
the extraordinarily high concentrations ranging from 10μM to 100μM in neurons and lethality if 
its gene is deleted (Xia and Storm, 2005).   
 
Fig. 1.8. Ribbon presentations of CaM and CaM in complex with target peptides. CaM is colored blue and Ca2+ ions 
are yellow.  The N- and C- lobes are at the ends of the molecule connected a central α-helical linker in Ca2+/CaM.  
The linker collapses in apo-CaM.  Structural data were taken from the Protein Data Bank, accession codes: apo-CaM 




Several hundred Ca2+-binding proteins have been identified to contain the EF-hand Ca2+ 
binding motif.  This motif comprises about 30 amino acids and consists of a helix-loop-helix 
where the two helices are arranged similar to the extended thumb and index finger of a hand: it is 
commonly called the EF-hand domain.  In almost all Ca2+-binding proteins such as CaM, two 
EF-hand domains are in close proximity forming an EF-hand pair.   
CaM is a dumbbell shaped molecule with two EF-hand pairs: the N- and C- lobes that are 
arranged one at each terminus connected by a long linker (Fig. 1.8). Each lobe binds two Ca2+ 
ions, and is connected to each other by an α-helical linker that bends with changes in intracellular 
Ca2+ concentration (Vetter and Leclerc, 2003).  The lobes share 48% sequence identity and 75% 
similarity, a difference that is reflected in 10-fold higher Ca2+-binding affinity of the C-lobe.  
The average dissociation constant of Ca2+ from CaM is 15μM in the absence of other proteins.  
The affinity for Ca2+ increases when CaM is complexed with a target protein and, with the 
exception of neurogranin and neuromodulin, Ca2+ recruitment enhances CaM’s affinity for its 
targets (Olwin and Storm, 1985).  These changes in affinity occur because Ca2+ binding exposes 
a hydrophobic patch, the main site of interaction between CaM and its targets (Xia and Storm, 
2005).   
 Recent observation have shown that CaM is an important regulator of many different 
ionic currents by binding to and modulating the functions of channel receptors, such as the rod 
cGMP gated cation channel, NMDAR, calcium activated potassium channel and the voltage-
gated calcium channel (VGCC) (Schumacher et al., 2001; Petegem et al., 2005) (Fig 1.9).  CaM 
acts as an intracellular calcium sensor for these channels when bound to them, thus translating 




Fig. 1.9.  Summary of CaM binding proteins (O’Day, 2003).  CaM target proteins are varied in function and 
localisation, ranging from structural proteins to transcription factors. 
 
1.5.3 The role of post-translational modifications in regulating receptor activity 
Post-translational modifications (PTMs) are covalent processing events that change the 
properties of a protein by proteolytic cleavage or by the addition of a modifying group to one or 
more amino acids (Fig. 1.10).  PTMs of a protein can determine its activity, state, localization, 
turnover, and interactions with other proteins (Mann and Jensen, 2003).  Proteolytic cleavage can 
relieve auto-inhibition, or release a protein for folding and function after secretion.  
Modifications like hydroxylation, acetylation, methylation, ubiquitination and phosphorylation 
are frequently utilised for controlling protein interactions by completing substrate recognition 
sites of a target protein (Table 1.1).  Kinase cascades are turned on and off by the reversible 
addition and removal of phosphate groups (Cohen, 2000), while ubiquitination marks targeted 




Fig. 1.10.  Comparison of the in vivo (with PTMs) and in vitro (without PTMs) states a protein experiences, 
highlighting several regulatory modes conferred by post-translational modifications (Saghatelian and Cravatt, 2005). 
 
 




Example 1: Phosphorylation 
One of the most common modifications to proteins is the phosphorylation of serine, 
threonine and tyrosine residues.  About 30% of all cellular proteins are phosphorylated at any 
time; abnormal phosphorylation is now recognized as a cause or consequence of many disease 
states (Cohen, 2002).  Phosphorylation and dephosphorylation is catalysed by protein kinases 
and protein phosphatases respectively, in order to modify the function of a protein by modulating 
its biological activity.  Phosphorylation events function to stabilise a protein or mark it for 
destruction, facilitate or inhibit movement between subcellular compartments, as well as initiate 
or disrupt its binding to substrates and binding partners.  
Iakoucheva et al., 2004 found that the majority of protein phosphorylation sites are 
contained in intrinsically disordered protein segments, such that a phosphorylation site should be 
embedded into a generally hydrophilic and conformationally flexible sequence environment.  
The simplicity, flexibility and reversibility of phosphorylation, coupled with readily available 
sources of ATP as a phosphoryl donor may explain why phosphorylation has been evolutionarily 
selected as the most common regulatory mechanism by eukaryotic cells. 
 
Example 2: Ubiquitination 
Definitive inhibition is most commonly mediated by activation-deactivation protein 
degradation.  The degradation of cellular signalling proteins following their ubiquitination plays 
a critical role in controlling multiple physiological processes.  To terminate a signal, activated 
proteins are removed from the membrane by endocytic mechanisms and either recycled or 
degraded, generating a refractory period before the next signal can be transmitted.  In cells, this 
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process is largely regulated by ubiquitination, where ubiquitin moieties are covalently attached to 
defined lysine residues within the target protein.  Ubiquitination is mediated through the 
sequential enzymatic cascade involving ubiquitin activating (E1), conjugating (E2), and ligating 
(E3) proteins.  Additional ubiquitin molecules can be added to the originally ubiquitinated 
lysines to generate ubiquitin chains.  The type and length of chain generated dictates the 
mechanism by which the protein is then downregulated.  Monoubiquitination directs a protein to 
internalization and endosomal sorting, while presence of multi-ubiquitin chains on proteins 
targets them for degradation by the 28S proteasome (Weissman, 2001). 
 
1.6 The importance of protein – protein interaction domains and motifs 
 Over the last decade, we have gained considerable insights into the mechanisms by which 
signals are accurately conveyed from receptors at the plasma membrane to targets in the 
cytoplasm and nucleus.  At the heart of the abovementioned interactions, specificity and 
regulatory processes is a recurring theme of molecular recognition.   
Proteins recognize and bind to each other through stretches of amino acid sequences built 
into certain architectural folds known as domains.  Each domain typically comprises 50 - 200 
amino acids and folds into a discrete entity (Fig. 1.11), with its N- and C- termini juxtaposed in 
space and away from the interaction region (Schlessinger and Lemmon, 2003).  This enables it to 
be inserted in tandem with other domains on the same protein without interference to its own 
binding (Pawson and Nash, 2003).  A domain usually recognizes a core determinant, with 
flanking or noncontiguous residues providing additional contacts and an element of selectivity.  
They can be broadly classified into four groups – those that bind (1) short peptide motifs, (2) 
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associate with other domains, (3) recognise non amino acids or (4) bind post-translationally 
modified amino acids. 
    
   
    
     
  
     
  
    
   
 
 
   
 
   
  
      
   
   
 
  
   
  
 
   
  
 
   
 
    
   
Fig. 1.11.  A list of protein interaction domains (Adapted from Pawson Lab; pawsonlab.mshri.on.ca).  Each domain 
is schematically represented by a different icon and not reflective of the true domain architecture. 
 
Interaction domains may target proteins to a specific subcellular location, provide a 
means for recognising post-translational modifications or chemical second messengers, nucleate 
the formation of multiprotein signalling complexes, and control the conformation, activity, and 
substrate specificity of enzymes (Pawson and Nash, 2000).  Sometimes, individual domains 
engage several distinct ligands either simultaneously or at successive stages of signalling. 
27 
 
Since the entire cellular function organized in signal transduction networks is built on a 
restricted group of protein domains, each class of domains must have multiple biological 
functions and act in a combinatorial fashion, since there is insufficient variety to have each 
assuming a single biological role (Pawson and Nash, 2000).  The incorporation of different 
domains into a single polypeptide is nature’s way of overcoming the limitation of a few thousand 
gene products having to control the entire signalling network.  Multiple domains may interact 
with different sites on the same target, as commonly occuring in polypeptides that possess 
tandem SH2 domains, thereby increasing both the affinity and specificity of protein-protein 
interaction (Ottinger et al., 1998) or engage in complex intramolecular interactions that regulate 
the enzymatic activities of their host protein.   
Regulatory proteins also make use of such domains to their advantage.  They are often 
constructed from domains that mediate molecular interaction or have enzymatic activity to 
competitively inhibit association of a protein to its substrate (Pawson and Nash, 2003). The cell 
therefore uses a limited set of interaction domains, which are joined together in diverse 
combinations, to direct the actions of regulatory systems. 
 
1.7 Case study 1: Cbl regulation of receptors with tyrosine kinase activity  
 The c-Cbl proto-oncogene was first discovered through studies of hemopioetic tumours 
of mice infected with the Cas-Br-M retrovirus.  The isolated recombinant retrovirus induced pre- 
and pro-B lymphomas and caused the transformation of rodent fibroblasts.  The causative 
retrovirus was called Cas-NS-1 and its oncogene, v-Cbl, for Casitsas B-lineage lymphoma 
(Langdon et al., 1989).   Subsequent cloning of the mouse c-Cbl gene revealed that v-Cbl 
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encoded the first 355 amino acids of a longer 120kDa ubiquitously expressed full length protein, 
and overexpression of wild-type c-Cbl did not promote tumourgenesis (Blake et al., 1991).   
Two other mammalian homologues, b-Cbl and Cbl-c have since been identified.  All 
three family members share a highly conserved N-terminus that corresponds to residues in v-Cbl.  
Originally assigned as an adaptor protein, Cbl proteins were revealed to possess E3 ubiquitin 
ligase activity through an adjacent RING domain that recruits E2 ubiquitin conjugating enzymes.  
An extreme C-terminal ubiquitin-associated domain overlaps a leucine zipper motif.  Between 
the RING and the latter is a proline rich region for associations with SH3 domains (Fig. 1.14A). 
 About 150 proteins have been shown to be regulated by Cbl proteins (Fig. 1.12).  More 
recently, it was found to play a prominent role in mediating ligand dependent downregulation of 





Fig. 1.12.  The Cbl interactome(Schmidt and Dikic, 2005).  An Osprey diagram of proteins currently known to 
interact with Cbl.  Proteins were grouped according to the domains in Cbl to which they bind, which are represented 
by node colours and the colours in the centre.  Methods that were used for the detection of protein-protein 
interactions are represented by different line colours.    
 
1.7.1 RTK ubiquitination by Cbl in the context of EGFR and Met 
In the context of signalling by the EGFR, one of the first proteins to be recruited to the 
phosphorylated dimerised activated EGFR is Grb2, which can then recruit Cbl proteins from the 
cytoplasm to the plasma membrane through interactions with the proline rich region on Cbl and 
the SH3 domain on Grb2.  Autophosphorylation of EGFR also creates additional docking sites 
for the TKB domain of Cbl (Fig. 1.13).  Y1068 constitutes a direct binding site for the c-Cbl 
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tyrosine kinase binding (TKB) domain and is required for c-Cbl mediated ubiquitination and 
degradation of EGFR (Levkowitz et al., 1999).  Mutation of residues that comprise the c-Cbl 
TKB domain binding site elicits stronger mitogenic signals than the wild type receptor 
(Waterman et al., 2002).  Up to 40% glioblastomas express oncogenic mutants that disrupt Cbl’s 
interaction with EGFR.  The deregulation of Src which occurs in human brain, breast, colon and 
lung cancers also leads to the stabilization of the EGFR by promoting Cbl ubiquitination and 
degradation (Bao et al., 2003).  Throughout its internalization route, the prevailing role of Cbl 
seems to be retaining receptors inside the sorting endosome by promoting and maintaining their 
ubiquitination (Schmidt and Dikic, 2005). 
Met represents another class of RTK regulated by Cbl.  The c-Cbl TKB domain also 
binds to a juxtamembrane tyrosine (1003) residue.  This interacton is essential for ubiquitination 
and degradation of the receptor (Preschard et al., 2001).  The Y1003F mutant has a prolonged 
half life and is oncogenic in cell culture and tumourgenesis assays, identifying c-Cbl and 
ubiquitination as important negative regulators of this protein. 
 
 
Fig. 1.13.  The endocytotic and degradation pathway of 
EGFR via ubiquitination by c-Cbl (Ryan et al., 2006).  
Phosphotyrosines in activated EGFR serve as sites for Cbl 
to dock and orientate to a position favourable for 
ubiquitination.  Cbl recruits the E2 ubiquitin ligase to its 
RING domain which adds ubiquitin moieties to target 
lysine residues in EGFR.  The whole complex becomes 
internalized by clarithrin mediated endocytosis and 





1.7.2 NRTK regulation by Cbl 
 The relationship between Cbl and NRTKs is complex.  Cbl regulates NRTK activity 
through ubiquitination and degradation.  At the same time, it is also being regulated by NRTKs 
through phosphorylation.  c-Cbl has 22 Tyr residues available for phosphorylation at the C-
terminus and is a prominent substrate of PTKs.  700Y, 731Y and 774Y are principal 
phosphorylation sites (Feshchenko et al. 1998) by Syk and Src family kinases.  Phosphorylated 
Cbl becomes targets for auto-ubiquitination to remove its activity, resulting in prolonged RTK 
signaling.  However, Cbl overexpression also suppresses the activity of Syk, its homolog ZAP-
70 and c-Src kinase activity in a TKB dependent manner by binding to phosphorylated tyrosines 
of the activated kinases (Sanjay et al., 2001).  The complexity of c-Cbl’s regulation of Src 
signaling show that Cbl can have both positive roles, by functioning as an adaptor to contribute 
to signal transduction, as well as negative roles, by downregulating Src kinase activity or 
enhancing its degradation. 
 
1.7.3 The importance of Cbl-TKB domain in PTK regulation 
 While there are two families of domains that bind pTyr containing sequences – the 
phosphotyrosine binding (PTB) domain and the SH2 domain – only about a quarter of the 79 
known human PTB domains have acquired a capacity for pTyr dependent recognition 
(Schlessinger and Lemmon, 2003).  SH2 domains, however, are wholly dedicated to recognising 
pTyr and thus represent the largest class of known pTyr recognition domains for primary 
targeting and specificity elements in tyrosine kinase signalling (Pawson et al., 2001).  Each SH2 
domain has the ability to preferentially bind a specific phosphorylated motif (Songyang et al., 
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1993).  Since its discovery, a total of 120 different SH2 domains contained in 110 proteins from 
11 functional categories have been discovered, including Cbl family of proteins.  
c-Cbl interacts with a diverse array of proteins via phosphorylatable tyrosine residues at 
its C-terminus (Feshchenko et al. 1998), via its proline-rich region, and through the highly 
conserved N-terminal phosphotyrosine-like binding domain (Schmidt and Dikic, 2005). 
Although this phosphotyrosine binding domain (PTB) appeared to have several hallmarks of a 
PTB consensus motif, the crystal structure demonstrated that it structurally resembled an SH2 
domain but required a flanking four-helix bundle (4H) and an EF-hand subdomain to accomplish 
binding (Meng et al., 1999). Together, these three sub-domains make up the tyrosine kinase-
binding (TKB) domain, which is unique to Cbl proteins and often referred to as a specialized or 
'embedded' SH2 domain (Liu et al., 2006).  Several oncogenic RTKs have lost the ability to 
recruit Cbl in a TKB mediated manner. Moreover, the stability of Cbl itself is regulated by 
ubiquitination.  Tyrosine phosphorylation of c-Cbl by c-Src promotes auto-ubiquitination of Cbl 
and its degradation in a proteasome dependent manner (Yokouchi et al., 2001). 
Binding to the TKB domain is required for the subsequent conjugation of ubiquitin 
through the RING domain during the ubiquitination process. The consensus binding sequence 
targeted by the TKB domain was originally identified by Lupher et al. (1997) as D(N/D)XpY, 
but was later experimentally refined as (N/D)XpY(S/T)XXP. This motif is common to several 
PTKs, such as epidermal growth factor receptor (EGFR), colony-stimulating factor 1 receptor, 
ZAP-70 ζ-associated protein of 70 kDa, Src and Syk, as well as members of the Sprouty (Spry) 
family of Ras/mitogen-activated protein kinase inhibitors.  Each of these targets binds to the 
TKB domain following phosphorylation of a central tyrosine residue in the consensus motif and, 
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in most cases, their protein expression levels are subsequently downregulated by ubiquitination 
(Schmidt and Dikic, 2005). 
In recent years, two additional consensus motifs have been identified as targeted by the c-
Cbl-TKB domain (Fig. 1.14B). The first, RA(V/I)XNQpY(S/T), is a derivation of the original 
sequence, with conserved residues extending back to the arginine at the pY-6 position. This 
sequence is conserved amongst a family of adaptor proteins based on the APS (Adapter with a 
Plekstrin homology and Src homology-2 domains) protein (Hu and Hubbard, 2005) and, unlike 
the PTKs, they are not substrates for ubiquitination, but use c-Cbl as a docker protein in the 
insulin receptor complex (Chiang et al., 2001). The second consensus sequence was identified in 
a study investigating the binding of c-Cbl to the c-Met receptor (Met) but, unlike the APS 
sequence, it bears no resemblance to the previously characterized PTK-binding motif (Peschard 
et al., 2001). Alanine-scanning mutations identified that a DpYR motif was essential for the 
ubiquitination and downregulation of Met by c-Cbl (Peschard et al., 2004). This motif is 
conserved among the Met family members, Ron and Sea (Penengo et al., 2003), as well as in 







Fig. 1.14.  Schematic representation of c-Cbl 
domain architecture and targets of its TKB 
domain (Ng et al., 2008).  (A) Structural 
organization of human c-Cbl. The N-terminal 
region contains the TKB comprising 4H, EF-hand 
(EF) and SH-2-like subdomains. The TKB 
domain is separated from the RING domain by a 
short linker (L) region. Cbl has a proline-rich 
stretch following the RING domain and a 
ubiquitin-associated (UBA) domain at its C 
terminus. (B) Sequence alignment of previously 
characterized c-Cbl-TKB binding sites for the 
PTK, APS and Met subgroups of proteins. 
Coloured residues refer to the conserved residues 
in the sequence: pY is coloured red, (pY-2)D/N is 
green, (pY+1)S/T is dark blue, (pY+4)P is 
fuschia. (pY-6)R in the APS family is orange, 
(pY-5)A is brown and the (pY-4)Φ represents a 
hydrophobic residue, coloured violet. pY flanking 
residues of the Met family (pY-1)D are coloured 






1.8 Case study 2: CaM regulation of the VGSC receptors 
 Besides with the voltage-gated potassium channel whose repolarization properties are 
modified by ERK2 phosphorylation, the voltage-dependent sodium channel (VGSC) is the other 
basic component of action potentials in many excitable cells.  There are nine isoforms of the 
VGSC, Nav1.1 - Nav1.9, all of which generate the upstroke or depolarization of the action 
potential in various tissues (Fig. 1.5).  The α-subunit of VGSC is the main component of the 
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channel responsible for voltage-sensitive gating and selective ion permeation (Catterall, 1995), 
and the function of this α-subunit can be modulated through its interaction with associated 
proteins in regulating the generation of action potentials.   
Through sequence analyses, the C-termini of all VGSC subtypes were found to possess a 
conserved region for CaM interaction.  As Ca2+ has a fundamental role in the coupling of cardiac 
myocyte excitation and contraction, the first evidence of CaM modulating the VGSC came from 
the human cardiac sodium channel subtype Nav1.5, which binds to CaM in a calcium dependent 
manner.  This binding significantly enhances slow inactivation.  Mutations that disrupt CaM 
binding eliminated Ca2+/CaM slow inactivation (Tan et al., 2002).  Subsequent studies by 
Herzog et al. (2002) revealed that skeletal muscle Nav1.4 and neuronal subtype Nav1.6 are high 
affinity binders of CaM in the presence and absence of Ca2+.  The functional expression of 
Nav1.4 is critically dependent on the ability of the channel to bind CaM at the C-terminus, while 
the VGSC in Paramecium is dependent on CaM for activation (Saimi and Ling, 1995).  Mutation 
of the core amino acids in the CaM binding region of Nav1.6 decreased current amplitude 
significantly, albeit to a smaller extent than Nav1.4.  Changes in the intracellular concentration 
of Ca2+ altered inactivation kinetics of Nav1.6 currents via a CaM-dependent mechanism.  
Ca2+/CaM slowed Nav1.6 channel inactivation by 50%, while calcium free CaM enhances the 
rate of inactivation.  The Ca2+/CaM dependent slowing of Nav1.6 inactivation kinetics could 
prolong action potential duration to enhance neurotransmitter release at nerve endings, and play a 





1.8.1 The importance of the IQ motif in VGSC regulation 
 CaM binding proteins possess a basic often amphipathic stretch of residues that assumes 
an α-helix upon binding with CaM.  These motifs contain critical hydrophobic residues at 
positions 1, 8 and 14 and frequently an additional hydrophobic contact at position 5.  Basic 
amino acids are distributed throughout the motif and often flank the critical hydrophobic 
residues.  The consensus sequence of CaM binding motif is IQxxxRGxxxR and referred to as the 
IQ motif, after the first two conserved residues.   
Alignment of all known IQ motifs show that the residue at position 1 that may be Ile, Leu 
or Val.  Position 2 is always Gln, 7 may be ambiguous for several residues and the 11th position 
can be either Arg or Lys (Table 1.2).  The sequence (FILV)Qxxx(RK)Gxxx(RK)xx(FILVWY) 
thus represents a more generalised core IQ motif.  Two or three partially conserved Ala residues 
may be located at the N-terminal of the primary motif.  The entire region of the IQ domain 
comprising of core and flanking residues is 20-25 residues with no proline to form an 
uninterrupted seven-turn α-helix.  Partial amphipathicity with a net positive charge usually 
between 2+ to 5+ is commonly observed, although not neccessary.   
Most IQ motifs show preferential binding when Ca2+ is present, however, in other cases, 
proteins bind both in the presence and absence of Ca2+.  It has been suggested that IQ motifs 
containing a conserved Gly at the seventh position and a second basic residue do not require 
calcium to bind calmodulin, while binding of incomplete IQ motifs lacking the second basic 
residue is calcium dependent (Houdusse and Cohen,1995; Munshi et al., 1996).  The substitution 
of the 7th glycine with residues possessing bulky side chains, which occurs in approximately 50% 
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of IQ domains, may provide some specificity for calmodulin interactions, as might the identity of 





In the crystal structures of CaM bound IQ motif complexes, the IQ domain was observed 
to run through the structure of CaM between N- and C-termini lobes.  Exact positioning of the 
motif, however, differs between proteins. 
The IQ motif at the C-termini of K+ and Ca2+ ion channels, together with the voltage-
gated sodium channels (VGSC) enables CaM to functionally modify their function (Fig. 1.15).  
Disruption of VGSC regulation by CaM through mutation of the IQ motif has been linked to 
abnormalities linked to life-threatening idiopathic ventricular arrhythmias in cardiac muscle 
(Veldkamp et al., 2000; Wang et al., 2000; Tan et al., 2002).  Similarly, a proposed link between 
increased Ca2+ concentration, CaM kinase II activity and myotonia suggests that skeletal muscle 
VGSCs may be implicated (Deschenes et al., 2002).  A study of an individual with autism 
indicated that a mutation identified in the C-terminus of human Nav1.2 might reduce the binding 
affinity of Nav1.2 for Ca2+/CaM (Weiss et al., 2003).  Although the physiological relevance of 
altered inactivation kinetics in other VGSCs caused by disrupting CaM binding has yet to be 
ascertained, it remains conclusive that Ca2+ plays an important role through CaM-IQ motif 
interaction and regulates VGSCs in an isoform-specific way.  
 
Fig. 1.15.  Sequence alignment of the CaM interacting motif (IQ motif) within the C-termini of VGSC isoforms 
Herzog et al., 2003).  Identical and highly conserved residues are shaded in black and grey respectively from a 
schematic GST-fusion protein with the 250 amino acid long C-terminus of a sodium channel, indicating the position 




1.9 Chapter summary 
 The ERK/MAPK pathway is a ubiquitous serine/threonine kinase cascade directing 
growth, differentiation and plasticity in various tissues.  It is initiated by multiple receptor inputs 
that converge at levels downstream of Raf through to ERK1/2.  Regulating receptor activity 
instead of the MAP kinase module has certain advantages.  Firstly, Raf, MEKs and ERKs are 
entities common to all ERK/MAPK pathways: regulating upstream events, such as at the 
receptor level, enables signalling from a certain receptors to be specifically controlled without 
affecting signals from other receptors.  Secondly, it allows an unambiguous attenuation of an 
unwanted signal at its source.   
Like all signalling proteins, receptors leading to the ERK/MAPK pathway require 
interaction with other factors be functional.  Evolution has thus selected for the incorporation of 
molecular recognition domains within these proteins.  Regulatory proteins also exploit these 
domains in order to latch on to substrates for their purposes.  With the examples of regulatory 
proteins c-Cbl, Sprouty and CaM, this thesis explores the effects of regulatory strategies such as 
post-translational modifications, competitive inhibition and functional modifiers.  Through the 
use of three unique classes of receptors (RTKs – receptors with enzymatic activity, NRTKs – 
intracellular receptors and VGSCs – ion channel receptors), this thesis seeks to address the 
importance of protein interaction domains in the regulation and modulation of ERK/MAPK 
signalling across all receptor types. 
In the next chapter (Chapter II), the implication of protein phosphorylation in MAPK 
signal regulation by c-Cbl TKB domain is emphasized.  Together with biophysical and molecular 
quantization on the contribution of certain residues to its binding capacity, the basis of substrate 
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alignment on the TKB domain is thoroughly described.  The third chapter describes a calcium-
dependent regulation of the voltage-gated sodium channel by calmodulin and its implication in 
the neuronal MAPK processes of learning and memory, an interaction mediated by the IQ motif.   
Both the Cbl SH2 domain and the calmodulin interacting IQ motif represent domains involved in 
signal regulation that are seemingly able to bind their partners in multiple ways – Cbl has an 
abnormally wide range of binding motifs, and IQ motifs complex with CaM in many orientations 
as observed from previously known structures. 
Through structural characterisation of protein-peptide complexes, the aim of this thesis is 
to explore whether common interaction mechanisms that govern the regulatory networks of Cbl 
and CaM with their respective, seemingly disparate, binding motifs exist, such that they can 




























Although the approximatey 120 documented SH2 domains use diverse strategies to 
aggregate signalling complexes, there is no precedent for a given SH2 or PTB domain to 
associate with such apparently unrelated consensus binding motifs as seen with the TKB domain.  
Cbl proteins appear to have two major physiological functions—either in acting as scaffolds or in 
targeting proteins for ubiquitination (Thien and Langdon, 2005). These functions are reflected in 
the purpose of the TKB domain in (a) recognizing proteins and, in the case of ubiquitin 
substrates, (b) ensuring its appropriate orientation for ubiquitin conjugation. Cbl proteins have 
critical roles in the downregulation of both RTKs in growth and differentiation and the antigen 
receptors in the control of immune responses, and thus elucidating the TKB recognition sequence 
has been central to understanding the biochemistry of tyrosine kinase downregulation by Cbl 
proteins. The TKB domain is, in essence, an 'embedded' SH2 domain—a domain generally 
recognized to bind a 'tight' consensus motif (Liu et al., 2006). The abnormal range of the 
experimentally observed motifs that bind to the TKB domain invites the question as to whether 
this domain has an uncharacteristic flexibility of binding or whether there is a hitherto 
undiscovered common binding mechanism that encompasses the previously observed sequences. 
Furthermore, with such diverse sequence recognition strategies, binding affinity to c-Cbl is likely 
to be varied and may lead to the selective sequestration of c-Cbl by higher-affinity targets over 
lower-affinity ones. This model has been suggested as a mechanism whereby Spry2, the most 
well-characterized of the Spry proteins, recruits c-Cbl from EGFR and results in the 
ubiquitination of Spry2 and preservation of EGFR on the cell surface (Wong et al., 2002; Hall et 




2.2 Materials and methods 
2.2.1 Plasmid constructs, cloning, expression and purification 
The human c-Cbl-TKB domain (residues 25–351; Cbl-TKB) was cloned into pGEX4T-1 
expression vector (GE Healthcare, Buckinghamshire, UK), overexpressed as a glutathione-S-
transferase fusion protein and purified according to Meng et al., (1999) with modifications. The 
purified protein (1 mg/ml) was kept in a storage buffer (20 mM Na-HEPES pH 7.0, 0.2 M NaCl) 
and used for crystallization and ITC experiments. Wild-type full-length constructs of FLAG-
tagged Spry2, Spry4, FGFR1, HA-tagged c-Cbl and EGFR have been described previously 
(Wong et al., 2001). pBABE-bleo human insulin receptor B (IR-B) plasmid 11211 was from 
Addgene (deposited by Dr C Ronald Kahn; Entingh et al., 2003). Rat myc-tagged APS was 
kindly provided by Dr W Langdon (University of Western Australia). c-Met was from Origene 
Technologies Inc. (Rockville, MD) and subcloned into PXJ40 vector (courtesy of Dr E Manser, 
Institute of Molecular and Cell Biology) using NotI/NotI restriction sites. Point mutations in 
FLAG–Spry2 and HA–Cbl were generated by site-directed mutagenesis using Pfu DNA 
polymerase from Promega (Madison, WI). 
 
2.2.2 Complex formation and crystallization 
Tyrosine phosphorylated peptides of Human Sprouty2 49–61 (Spry249–61), Sprouty4 69–
81 (Spry469–81), EGFR 1063–1075 (EGFR1063–1075), Syk tyrosine kinase 317–329 (Syk317–329) and 
Met receptor 997–1009 (Met997–1009), (Sigma Genosys) were reconstituted in Cbl-TKB storage 
buffer and incubated with the purified Cbl-TKB in two-fold molar excess at room temperature 
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for 1 h for complex formation. The Cbl-TKB:peptide complexes were concentrated to 5 mg/ml 
in Amicon Ultra ultrafiltration devices (Millipore, Billerica, MA). Complexes were screened for 
crystals against crystal screen kits from Hampton Research, CA and Jena Biosciences, DE using 
hanging drop and under oil vapour diffusion methods respectively.  Initial crystallization 
conditions were optimised by varying precipitant or additive concentrations. 
 
2.2.3 Data collection, structure determination and refinement 
Data for the Cbl-TKB:EGFR1063–1075 complex crystals were collected with an R-axis IV++
 
 
image plate detector mounted on a RU-H3RHB rotating anode generator (Rigaku Corp., Tokyo, 
Japan). Data for all other complex crystals were collected at X29 beamline in the National 
Synchrotron Light Source, Brookhaven National Laboratory (Upton, NY). Data were processed 
and scaled with HKL2000 (Otwinowski and Minor, 1997). The TKB domain of c-Cbl from the 
ZAP70:Cbl complex structure, PDB code 2CBL (Meng et al., 1999) was used as a starting model 
for molecular replacement solution using the programme Molrep (Vagin and Teplyakov, 1997). 
Subsequent rigid body refinement reduced the R-factors close to 30%. At this stage, the 
calculated difference electron density map clearly showed the presence of substrate peptides. 
Model building and refinement were carried out in O (Jones et al., 1991) and CNS (Brunger et 
al., 1998) programmes, respectively. After several cycles of map fitting and refinement the R-




2.2.4 Protein Data Bank accession code 
Coordinates and structure factors of all of the Cbl-TKB:phosphopeptide complexes have 
been deposited with RCSB Protein Data Bank with codes 3BUM (Spry2), 3BUN (Spry4), 3BUO 
(EGFR), 3BUW (Syk) and 3BUX (Met). 
 
2.2.5 Isothermal titration calorimetry (ITC) 
Both phosphorylated and unphosphorylated peptides of Spry249–61, Spry469–81, EGFR1063–
1075, Src tyrosine kinase (Src413–425), Syk317–329, VEGFR (VEGFR11327–1338), VEGFR11327–1338 
V1331N mutant, VEGFR11327–1338 L1332R mutant, c-Met997–1009 and macrophage stimulating 1 
receptor 1011–1023 (Ron1011–1023
 
) were titrated against 10.8μM Cbl-TKB in a VP-ITC 
microcalorimeter (Microcal, Northampton, UK) performed under identical conditions. All 
peptides were maintained in storage buffer at 22°C and titrated in 10 μl injections into Cbl-TKB 
also in storage buffer. The heat of dilution, determined by titrating peptide into storage buffer, 
was subtracted from the raw data before curve fitting and refinement. The dissociation constants 
of Cbl-TKB to the various peptides were determined by least squares method and the binding 
isotherm was fitted using Origin v7.0 (Microcal) assuming a single-site binding model. All 





2.2.6 Antibodies and reagents 
Rabbit anti-Cbl (C-15), anti-FGFR1 (C-15), anti-Myc (A-14), anti-EGFR (1005), anti-
Grb2 (C-23) anti-insulin Rβ (C-19), and mouse anti-Myc (9E10) and anti-EGFR (528) were 
from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse anti-c-Cbl and anti-Grb2 were from 
Transduction Laboratories (Lexington, KY). Mouse anti-Met (25H2) was from Cell Signaling 
Technology (Beverly, MA) and rat anti-HA was from Roche Diagnostics (Basel, Switzerland). 
Mouse anti-FLAG, rabbit anti-HA, goat anti-HGFR, agarose-conjugated anti-FLAG M2 beads, 
recombinant human (rh) FGF-2, and goat anti-rabbit-HRP and anti-mouse-HRP were from 
Sigma Aldrich (St Louis, MO). rhEGF was from Upstate Biotechnology Inc. (Lake Placid, NY) 
and rhHGF was from Calbiochem (EMD Chemicals, San Diego, CA). 
 
2.2.7 Cell culture and transfection 
Human embryonic kidney 293T cells (ATCC, Manassas, VA) were cultured, maintained 
and transfected as previously outlined (Wong et al., 2001; Yusoff et al., 2002). For binding 
between WT c-Cbl and Spry2 point mutants, cells were transfected with FLAG–Spry2 and 
FGFR1 for 16 h and precipitated for endogenous c-Cbl. Cells were transfected with WT c-Cbl or 
Cbl bearing various point mutations with WT Spry2, Spry4, Met, EGFR or APS with IR-B for 
16 h or 40 h (in the case of Met). For Spry2, Spry4 or Grb2 experiments, cells were stimulated 
with 20 ng/ml FGF-2 for 2 h.  Met-transfected cells were stimulated with 100 ng/ml of HGF 30 
min. EGFR-transfected cells were stimulated with 100 ng/ml of EGF for 10 min. For APS 
experiments, cells were stimulated as described previously (Hu and Hubbard, 2005). 
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2.2.8 Cell lysis, immunoprecipitation and western blotting 
Cells lysis and western blotting was performed as described previously (Wong et al., 2001). 
Immunoprecipitation was carried out using FLAG–M2 beads (Spry2), anti-HA (c-Cbl), anti-


















2.3.1 Purification of recombinant Cbl 
 The human c-Cbl-TKB domain (residues 25–351; Cbl-TKB) was cloned into pGEX4T-1 
plasmid vector (GE Healthcare, Buckinghamshire, UK) and transformed into Escherichia coli 
expression strain Rosetta.  100ml of Luria-Bertani (LB) media supplemented with 100μg/ml 
ampicillin was inoculated with one colony of Rosetta(pGEX4T1-Cbl-TKB) and grown overnight 
at 37ºC with aeration.  The overnight culture was amplified to 1L medium and protein expression 
induced with 0.1mM isopropyl-thio-galactoside (IPTG) for 16h at 20ºC during mid-log phase of 
cellular growth.   
 GST-fused Cbl-TKB was harvested by six cycles of 1min sonication with 40sec interval 
between cycles.  Cbl-TKB in the cleared lysate was purified and cleaved on GST-sepharose (GE 
Healthcare, Buckinghamshire, UK) as described by Meng et al., 1999.  Cbl-TKB was purified to 
homogeneity by gel filtration using Superdex G200 column (GE Healthcare, Buckinghamshire, 
UK), eluting at 80ml as a single symmetrical peak (Fig. 2.2) and migrating as a single band in 














Fig. 2.1. Purification profile of Cbl-TKB.  Samples from different stages of purification were collected, separated by 
12.5% SDS-PAGE and visualized by Coomassie staining.  GST fused Cbl-TKB was bound to GST-Sepharose and 




Fig. 2.2.  Gel filtration profile of cleaved Cbl-TKB in a 120ml column volume Superdex-200 column.  Cleaved Cbl-
TKB was purified to homogeneity by gel filtration and eluted in storage buffer.  Blue plot indicate Cbl-TKB gel 























































































































2.3.2 Verification of purified Cbl-TKB functional properties 
 Purified Cbl-TKB was incubated with increasing amounts of phosphorylated Spry249–61 
for 1h on ice. Glutaraldehyde, a cross-linking agent whose aldehyde groups that reacts with 
nitrogen atoms of amino acids in close proximity, was added with stirring to a final concentration 
of 0.1% after 1h of complex formation.  The covalently linked Cbl-TKB: Spry249–61 was 





Fig. 2.3.   Glutaraldehyde cross-linking of Cbl-TKB with various molar ratios of phosphorylated Spry246-61. 
Uncrosslinked Cbl-TKB (without adding glutaraldehyde) and uncomplexed, crosslinked Cbl-TKB (without Spry246-
61 peptide) were negative controls, while Cbl-TKB was complexed with Spry246-61 in various molar ratios as 
indicated above each lane. 
 
At low peptide concentrations, cross-linked Cbl-TKB was observed to form high 
molecular weight complexes that were unable to move into the separating gel, possibly due to the 
















































Cbl-TKB: Spry249–61 was increasingly observed to migrate as a band larger than the molecular 
weight of uncomplexed Cbl-TKB (Fig. 2.3).  This observation confirms that the structure of 
purified recombinant Cbl-TKB was preserved, since ligand binding requires all three sub-
domains of the TKB domain to be structurally intact (Meng et al., 1999). 
 
2.3.3 Crystallization 
 The ability of the TKB domain to bind to two different consensus motifs—
(D/N)XpY(S/T)XXP or DpYR—but still appropriately align the protein for ubiquitination 
suggests that there would be a common binding mechanism. The motifs on Spry2, EGFR, Syk 
and Met that recognize c-Cbl-TKB domain (herein referred to as Cbl-TKB) have previously been 
identified and, as Spry4 has three of the four conserved residues, it was also explored whether 
Spry4 binds to c-Cbl, as results for this are currently inconclusive.  Cbl-TKB was therefore 
concentrated to 5mg/ml and incubated with excess of phosphorylated Spry249–61, Spry469–81, 
EGFR1063–1075, Syk317–329, and Met997–1009 peptides.  Complexes were screened for crystals in 1μl 
protein to 1μl mother liquor hanging drops with 500μl reservoir solution.   
The initial crystals obtained were too small, too flat or twinned to be of diffraction quality 
(Fig. 2.4).  These initial conditions were optimized and finally each of the complexes crystallized 
in a different condition.  Cbl-TKB:Spry249–61 complex crystals grew in 0.1M Na-HEPES pH 7.5, 
75mM ammonium sulphate, 25% PEG3350 and 4% n-propanol; Cbl-TKB:Spry469–81 complex 
crystals grew in 0.2M Na/K tartrate and 20% PEG3350; Cbl-TKB:EGFR1063–1075 crystals grew in 
0.25M sodium formate and 20% PEG3350; Cbl-TKB:Syk317–329 crystals grew in 0.1M Bis-Tris 
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pH 6.5, 0.12M ammonium acetate and 18% PEG3350; Cbl-TKB:Met997–1009 crystals grew in 
0.15M malic acid and 20% PEG3350 (Fig 2.5).  
 
 
       
Cbl-TKB: Spry249–61                                                      Cbl-TKB: Spry469–81 
 
      






Fig. 2.4.  Initial crystals from the screening of Cbl-TKB complexed with phosphorylated peptides obtained using 
hanging drop vapour diffusion method.  These crystals were obtained from conditions in the Hampton Research 
Index Screen Kit (Hampton Research, CA). 
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Fig. 2.5.  Diffraction quality crystals of Cbl-TKB complexed with phosphorylated peptides obtained after initial 
crystals optimization using hanging drop vapour diffusion method.  These crystals were cryo-protected by 
dehydration method using mother liquor supplemented with increasing concentrations of glycerol and flash frozen in 
liquid nitrogen before data was collected. 
 
2.3.4 Data collection, structure determination and refinement 
 Except Cbl-TKB:EGFR1063–1075, all other complex crystals were diffracted at the X29 
beamline in the National Synchrotron Light Source, Brookhaven National Laboratory (Upton, 
NY).  The structures of the complex crystals between Cbl-TKB and the phosphorylated 13-mer 
peptides of these five proteins were determined between 1.35–2.60Å resolutions and crystallized 








Table 2.1.  Data collection and refinement statistics. 
Data collection Cbl-N Spry2 Cbl-N Spry4 Cbl-N EGFRa Cbl-N Syk Cbl-N Met 








50.00 – 1.35 
(1.40-1.35) 
 Space group P6 P6 P21 P21 P21 
 Unit cell (Å) a= b= 122.26 
c= 54.71 
 















 Molecules / a.s.u. 1 1 2 2 2 
 Reflections (total/unique) 528974/32750 566291/31352 59344/21945 181855/36701 930080/142157 
 Rsym (%)b 8.3 (34.6) 5.2 (15.1) 10.9 (33.5) 7.6 (25.4) 10.9 (23.6) 
 Completeness (%)c 99.9 (99.1) 96.3 (82.1) 91.9 (83.0) 92.7 (66.0) 95.0 (87.2) 
Refinementd      
 Resolution (Å) 20.00 – 2.00 20.00-2.00 20.00 - 2.60 20.00-1.45 20.00 – 1.35 
 Rwork (%)e 22.40(29469) 20.13(29166) 23.04(15455) 22.41(95507) 22.52(127952) 
 Rfree (%)f 26.24(2221) 24.24(2128) 27.48(2304) 23.84(2176) 23.98(2208) 
Average B-factors (Ǻ2) (no. of atoms)      
 Cbl-TKB 29.71(2489) 40.11(2489) 33.65(4980) 21.79(4994) 17.21(4994) 
 Peptide 25.94 (74) 48.82(63) 35.29(190) 33.02(162) 22.76(140) 
 Water 42.86(297) 53.97(355) 32.18(235) 30.71(575) 26.66(686) 
r.m.s.d bond lengths (Å) 0.009 0.010 0.009 0.006 0.006 
r.m.s.d bond angles (°) 1.24 1.36 1.32 1.10 1.11 
Ramachandran plotg      
 Most favoured regions (%) 89.8 90.5 81.3 89.3 89.1 
 Additionally allowed regions (%) 9.8 9.1 16.9 10.0 10.1 
 Generously allowed regions (%) 0.4 0.4 1.8 0.7 0.7 
 Disallowed regions (%) 0.0 0.0 0.0 0.0 0.0 
Values in parentheses indicate statistics for the highest-resolution shells. 
aNCS restraint was kept throughout the refinement of Cbl–TKB EGFR. 
bRsym = |Ii – <I>| / |Ii| where Ii is the intensity of the ith measurement, and <I> is the mean intensity for that reflection. 
cCompleteness = (number of independent reflections)/(total theoretical reflections). 
dFor all models, reflections with I>σI was used in the refinement. 
eR factor = 100 x Σ|FP – FP(calc) | / Σ FP. 
fR-free was calculated with approximately the same number of reflections in all the complexes’ test set. 
gStatistics for the Ramachandran plot from an analysis using PROCHECK (Laskowski et al, 1993). 
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Four of the five complexes resembled the binding pattern for c-Cbl with a phosphorylated 
peptide that has previously been identified, with several exceptions (Meng et al., 1999; Hu and 
Hubbard, 2005) (Fig. 2.6K), whereas the Met peptide bound to Cbl-TKB in the reverse 
orientation, with backbone directionality extending from C- to N- terminus. This reversed 
binding has not been observed for the TKB domain or for any other SH2 or PTB domain to date. 
The Cbl-TKB:Met complex 1.35Å resolution also represents the highest-resolution structure 
currently available for c-Cbl. The structure of the Cbl-TKB:peptide complexes for Spry249–61, 
EGFR1063–1075 and Met997–1009 are shown as ribbon diagrams to illustrate the position of the 
peptide relative to the subdomains of the TKB domain (Fig. 2.6A, E and I). Although the main 
site of interaction is at the SH2 region, all three subdomains must be intact before binding 
occurs.  In particular, the SH2 domain was found to shift and pack against the 4H upon ligand 
binding to complete the pTyr binding pocket (Meng et al., 1999).  The Cbl-TKB:peptide 
complexes for Spry469–81 and Syk317–329 resemble the Cbl-TKB:Spry2 complex (Fig. 2.6C and 
G).  Electrostatic surface representations for the Spry2, EGFR and Met complexes are shown in 
Figure 2.6B, F and J respectively and in the Figure 2.6D and H for Spry4 and Syk, demonstrating 
peptide binding and the surface morphology of the TKB domain. Electron density maps for each 
of the peptides are provided in Figure 2.7. In all of the complexes, extreme N- and C-terminal 






































Fig. 2.6. Crystal structure and electrostatic surface representations of TKB domain complexed with Spry2, Spry4, 
EGFR, Syk and Met (Ng et al., 2008). Crystal structures of the Cbl-TKB complexed with each of the peptides (A) 
Spry249–61 (cyan), (C) Spry469–81 (green), (E) EGFR1063–1075 (yellow), (G) Syk317–329 (grey) and (I) Met997–1009 (pink), 
and surface representations of the Cbl-TKB complexed with (B) Spry249–6, (D) Spry469–81, (F) EGFR1063–1075, (H) 
Syk317–329,  (J) Met997–1009 and (K) ZAP-70 phosphopeptide (Meng et al., 1999). The c-Cbl-TKB domain is shown as 
a ribbon diagram with helices, β-strands and loops coloured light brown. Phosphopeptides are shown as stick 
models. Intrapeptidyl H-bonds are shown as grey dotted lines. Residues at the extreme N and C termini of the 
phosphopeptides are disordered and not included. The figure was prepared using Pymol (DeLano, 2002) and the 





Fig. 2.7. Stereo diagrams showing omit electron density maps of (A) Spry249-61 (cyan), (B) Spry469–81 (green), (C) 
EGFR1063-1075 (yellow), (D)  Syk317–329 (grey) and (E) Met997-1009 (pink) peptides whose structures were solved in 
complex with Cbl-TKB (Ng et al., 2008).  Intra-molecular hydrogen bonds are shown as grey dotted lines.  With the 
exception of EGFR whose map was contoured at 1.6 σ level, all other maps were contoured at level 2.0 σ and 
calculated phases up to their maximum diffraction resolution as stated in Table 2.1.  The figure was prepared using 




2.3.5 Conserved residues in (D/N)XpY(S/T)XXP motif contribute to binding in varying 
degrees 
The Cbl-TKB:peptide interactions from the PTK subgroup—Spry2, Spry4, EGFR and 
Syk—are primarily mediated by 9–13 H-bonds (<3.2 Å) (Figure 2.8; Table 2.2). The essential 
pTyr residue occupies a positively charged binding pocket on Cbl-TKB and makes five to six H-
bond contacts with several residues of the TKB domain (Arg294, Ser296, Cys297 and Thr298), 
supporting previous reports that the pTyr contributes almost 50% of the free energy of 
association to c-Cbl binding (Liu et al., 2006). A close-up view of this interaction is shown for 
Spry2 and EGFR (Fig. 2.8A and C), with H-bonds represented by grey dotted lines, and an 
extended linear view of these interactions (Fig. 2.8B and D) with green dotted lines representing 
H-bonds. 
The interactions mediated by the other conserved residues of the PTK subgroup were 
more varied. The (pY+4)Pro of Spry2, Spry4 and EGFR peptides occupies a shallow 
hydrophobic cleft flanked by Tyr307, Thr317 and Phe336 on Cbl-TKB. The Syk peptide lacks 
this interaction and binds solely to the NXpY region, possibly further stabilized by additional H-
bonds with Asn79 of Cbl-TKB through its nonconserved (pY-4)Ser319, which is not observed 
with the other complexes. The conserved (pY+1)Ser/Thr residue of Spry2 and EGFR interacts 
with Gln316 of Cbl-TKB through a backbone–backbone H-bonding contact. However, this pY+1 
residue was more tolerant of degeneracy than expected, as the amide N of both (pY+1)Ile54 in 
Spry4 and (pY+1)Glu324 in Syk also formed backbone H-bonding contacts with Gln316 of Cbl-
TKB. This explains the lesser preference for conserved residues in the pY+1 position (Lupher et 
al., 1997), although residues with large side chains are likely to have steric clashes and may not 
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be preferred. In all five complexes, the backbone carbonyl O of the pY-1 residue forms a H-bond 
with the OH of Tyr274 on Cbl-TKB, irrespective of the pY-1 residue. 
 The (pY-2)Asn in the peptides of the PTK subgroup formed a H-bonding contact through 
the N of the carboxamide side group with the carboxyl O of Pro81 on Cbl-TKB, as shown for 
Spry2 (Figure 2.8A and B). The (pY-2)Asn of Syk forms an additional H-bond with Ser80, 
which is not seen with the other peptides. Interestingly, for EGFR, which lacks the conserved 
(pY-2)Asn, the (pY-1)Arg appears to assume this role by forming a H-bond with the carboxyl O 
of Pro81 in the 4H bundle of Cbl-TKB in a manner similar to the other complexes (Figure 2.8C 
and D). This 'rescue'-binding mechanism of EGFR may enable it to acquire a higher binding 
affinity than would be expected. 
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 Table 2.2. Hydrogen bonding interactions between Cbl-TKB and the various peptides 
Cbl-TKB Spry249-61 Spry447-59 EGFR1063-1075 Syk317-329 Met997-1009 
Asn79 Nδ2 
 





   Asn321 Oδ1, 2.52 Arg1004 NH1, 2.62 
Pro81 O Asn53 Nδ2, 2.90 Asn51 Nδ2, 3.04 Arg1068 NH1, 2.81 
Arg1068 NH2, 2.66 
 
Asn321 Nδ2, 3.09 Arg1004 NH2, 2.85 
Tyr274 OH 
 
Glu54 O, 2.68 Asp52 O, 2.80 Arg1068 O, 2.81 Pro322 O, 2.71 Asp1002 Oδ2, 2.58 
Arg294 NH1 
              NH2 
 
pTyr55 OH, 2.89 
pTyr55 PO3, 2.91 
 
 
pTyr53 OH, 2.89 
 
pTyr1069 PO2, 3.03 
pTyr1069 OH, 2.88 
pTyr323 PO2, 3.02 
pTyr323 OH, 2.93 
pTyr1003 PO2, 2.97 
pTyr1003 OH, 2.93 
Ser296 Oγ 
 
pTyr55 PO3, 2.76 pTyr53 PO3, 2.71 pTyr1069 PO3, 3.13 pTyr323 PO3, 2.72 pTyr1003 PO3, 2.67 
Cys297 N 
 
pTyr55 PO3, 2.98 pTyr53 PO2, 2.95  pTyr323 PO2, 2.92 pTyr1003 PO2, 3.04 
Thr298 Oγ1 
              N 
 
pTyr55 PO3, 2.55 
pTyr55 PO3, 2.89 
pTyr53 PO3, 2.70 
pTyr53 PO3, 2.88 
pTyr1069 PO3, 2.94 
pTyr1069 PO3, 2.77 
pTyr323 PO3, 2.56 
pTyr323 PO3, 3.01 
pTyr1003 PO3, 2.61 
pTyr1003 PO3, 2.99 
Tyr307 OH 
 
    Glu999 O, 2.53 
Gln 316 O 
 
               N 
 
Thr56 N, 2.84 
Thr56 Oγ1, 3.21 
Ile54 N, 2.84 Ser1070 N, 2.75 
 
 
Glu324 N, 2.85 pTyr1003 N, 2.86 
 
Asp1002 Oδ1, 2.88 
Thr317 Oγ1 
 
  Ser1070 O, 2.56   
His320 Nε 
              
 Asp55 Oδ2, 2.77 
 
   
Lys322 Nξ 
 
  Asp1072 Oδ2, 3.06   
Glu334 Oε1 
 
              Oε2 
   Thr1074 Oγ1, 2.96 
 
 Glu999 Oε1, 3.03 
Glu999 Oε2, 2.92 





Fig. 2.8. The conserved intrapeptidyl hydrogen (H) bond and neighbouring H-bonds for the conserved pTyr of 
Spry2, EGFR and Met (Ng et al., 2008). Close-up view of the tyrosine-binding pocket of the c-Cbl-TKB domain 
complexed with (A) Spry249–61 (cyan), (C) EGFR1063–1075 (yellow) and (E) Met997–1009 (pink) shows the conserved 
intrapeptidyl H-bonds between the pTyr and the (pY-2)Asn of Spry2 or the (pY-1)Arg of Met. Intrapeptidyl H-
bonds are shown as dotted red lines and other H-bonds are shown as grey dotted lines. The figure was prepared 
using Pymol (DeLano, 2002). A schematic linear extended view of the c-Cbl-TKB domain with (B) Spry2, (D) 
EGFR and (F) Met. The phosphopeptides are coloured red and the Cbl residues are blue. Residues participating in 
van der Waals contacts are highlighted in gold with the interacting surfaces as gold curved lines. H-bonds are 
indicated by green dashed lines and the intrapeptidyl H-bond is depicted by a black dashed line between the 




2.3.6 Met binds to the TKB domain in the reverse orientation 
 One of the more unexpected findings was that the Met peptide bound to c-Cbl-TKB 
domain in the reverse orientation from C to N terminus (Fig. 2.6I and J, 2.8E and F). This is 
contrary to previous modelling predictions (Peschard et al., 2004) and demonstrates that the 
conserved Asp1002 and Arg1004 residues have more than a supporting role for the pTyr in the 
binding of Met and c-Cbl. Similar to the other peptides of the PTK group, Met binding in the 
reverse direction forms six H-bond contacts from the essential pTyr residue with Arg294, 
Ser296, Cys297 and Thr298 on c-Cbl in a positively charged binding pocket (Fig. 2.8E and F), 
and similar to the binding with EGFR, the Arg1004 in Met substitutes for the missing (pY-2)Asn 
and forms H-bond contacts with Pro81. Arg1004 also forms an additional H-bond with Ser80, 
similar to that observed with the Syk complex, but not with the other phosphopeptides. 
 The Asp1002 residue in Met assumes the role of the conserved (pY+1)Ser/Thr in the 
PTK subgroup by interacting with Gln316 and Tyr274 on Cbl-TKB. In contrast to the modelling 
predictions by Peschard et al., (2004), neither the backbone carbonyl nor amino groups of either 
residue interact with Cbl-TKB, and no salt bridge is formed between the side chains of Asp1002 
and Arg1004 to orientate the phosphorylated tyrosine residue into its binding cleft on Cbl-TKB. 
Rather, the side chains of both residues are orientated into the Cbl-TKB:Met interface in the 
same direction as pTyr1003. The Glu999 residue of Met forms unique H-bonding contacts with 
Glu334 of the Cbl-TKB that is not observed in any other complex; its aliphatic part of the side 





2.3.7 An intrapeptidyl hydrogen bond is conserved across all TKB domain-binding 
proteins 
 Within the peptides of Spry2, Spry4 and Syk, the formation of an intarpeptidyl H-bond 
was observed between the (pY-2)Asn the phosphate oxygen (represented as a red dotted line in 
the Spry2 peptide in Fig. 2.8A, or a black dotted line in Fig. 2.8B when bound to the TKB 
domain. This H-bond was reported in earlier studies (Meng et al., 1999; Hu and Hubbard, 2005); 
however, no significance was assigned to its existence. The presence of this H-bond across all 
peptides with a (pY-2)Asn strongly suggests that it is evolutionarily conserved. In addition, a 
similar intrapeptidyl H-bond between the phosphate oxygen of the pTyr and the guanidium 
group of the Arg at the pY-1 position in the EGFR peptide (Arg1068) was also observed, which 
appears to be compensating for the loss of (pY-2)Asn (Fig. 2.8C and D). Likewise, with a 
reversal in the binding mode of the Met peptide, the same intrapeptidyl H-bond as seen in EGFR 
was also observed to form between the (pY+1)Arg1004 and the phosphate oxygen of the pTyr in 
the Met peptide (Fig. 2.8E and F). Taken together, these findings demonstrate that an 
intrapeptidyl H-bond between the pTyr and the (pY-2)Asn, the (pY-1)Arg or the (pY+1)Arg in 
the reverse orientation (hereafter also referred to as the adjacent Arg) is conserved across TKB 
domain-binding substrates, and we propose that this intrapeptidyl H-bond is essential for binding 






2.3.8 Full-length protein binding confirms that (pY-2)Asn and pTyr residues of Spry2 are 
indispensable for binding 
 To confirm and extend upon our structural studies using full-length proteins, the relative 
importance of each of the four conserved residues was tested by creating alanine point mutations 
in the TKB-binding motif of Spry2 and examining how this affects its interaction with 
endogenous c-Cbl under stimulated conditions (Fig. 2.9A). When compared to WT Spry2 
binding, it was observed that binding to c-Cbl was disrupted with the Spry2 N53A and Spry2 
Y55A mutants, reduced with the Spry2 T56A and P59A mutants and unaffected with the Spry2 
E54A mutant. This supports the crystal structure observations that (pY-2)Asn and pTyr are 
essential for Cbl-TKB binding and suggests that Cbl's interactions with T56A and P59A are 
important, but not essential for binding, whereas the nonconserved Spry2 E54A mutant is not 




Fig. 2.9.  Site-directed mutagenesis to determine the importance of conserved residues (Ng et al., 2008). (A) 293T 
cells were transfected with FGFR1 and FLAG-tagged wild-type Spry2 or Spry2 bearing alanine point mutations as 
indicated. The cells were lysed 24 h post-transfection and FLAG–Spry2 proteins were immunoprecipitated (IP) 
using FLAG–M2 beads. IP and total cell lysates (TCL) were immunoblotted with anti-Cbl (C-15), anti-FLAG or 
anti-FGFR1 (C-15) as labelled. (B) Diagram of c-Cbl with an enlargement of the TKB domain. The point mutations 
created in the SH2 subdomain of Cbl are described. (C–H) 293T cells were transfected with HA-tagged WT c-Cbl 
and Cbl bearing various point mutations as described in (B), along with (C) FLAG–Spry2, (D) Spry4, (E) EGFR, (F) 
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Met, (G) myc-APS in combination with insulin receptor-B (IR-B) or (H) alone for endogenous Grb2. Cells were 
stimulated as described in the Materials and methods and lysed 24 or 48 h post-transfection. In (C) and (D), anti-
FLAG and anti-Cbl IPs (C-15) and TCLs were immunoblotted with anti-FLAG and anti-HA (Cbl). In (E), anti-
EGFR IPs (528) and TCLs were immunoblotted with anti-HA (Cbl) and anti-EGFR (1005). In (F), anti-HGFR IPs 
and TCLs were immunoblotted with anti-HA and anti-Met (25H2). In (G), anti-myc IPs (A-14) and TCLs were 
immunoblotted with anti-HA, anti-c-myc (9E10) and IR-β (C-19). In (H), anti-Grb2 IPs (C-23) and TCLs were 
immunoblotted with anti-HA and anti-Grb2. 
 
 
2.3.9 Binding between full-length Cbl and its targets validates the peptide- and domain-
derived structural studies 
 To further validate the crystal structures, key residues on c-Cbl that were shown to 
mediate binding in the crystal structures were mutated (Fig. 2.9B) to test their interaction with 
WT proteins. In all cases, binding was observed for WT c-Cbl with Spry2 (Fig. 2.9C), Spry4 
(Fig. 2.9D), EGFR (Fig. 2.9E), Met (Fig. 2.9F) and APS (Fig. 2.9G). This binding was abrogated 
with the c-Cbl G306E mutant, a nonbinding mutation originally discovered in a genetic screen 
on Sli-1, the Caenorhabditis elegans homologue of c-Cbl (Levkowitz et al., 1999) that was 
shown to disrupt the binding with full-length ZAP-70 (Meng et al., 1999); included here as a 
negative control. 
As with the G306E mutant, a phenylalaine to Tyr substitution (Y274F) in c-Cbl also 
caused a loss of binding to Spry2, Spry4, EGFR and Met. The OH of Tyr274 on Cbl-TKB binds 
to the invariant backbone carbonyl O of the pY-1 nonconserved residue of Spry2, Spry4 and 
EGFR or the (pY-1)Asp of Met, which is tested and confirmed by the E45A mutant that retains 
binding (Fig. 2.9A). The side chains of residues Arg294, Ser296 and Thr298 on c-Cbl formed H-
bond contacts with the essential pTyr on all of the peptides, and this is confirmed by a loss or 
reduction in binding with alanine substitutions of these residues. The S296 residue, however, 
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appeared to be less important as some or all of the binding was retained. Phe336 participates in 
hydrophobic interactions with (pY+4)Pro, and an alanine substitution caused a reduction in 
binding between c-Cbl and all of the WT proteins, where present. (pY-4)Glu999 of Met occupies 
the same cleft, and an alanine mutation of its side chain causes a similar reduction in binding. 
Alanine point mutations were also included for K322 and E334 as the crystal structures 
showed specific interactions for EGFR (Asp1072) and both EGFR (Thr1074) and Met (Glu999), 
respectively. However, in addition to EGFR, we observed a reduction in binding for Spry2 and 
Met with the c-Cbl K322A mutant. K322 is a solvent-exposed residue, and an alanine mutation 
may alter the surface conformation of c-Cbl and reduce its binding with proteins that are in close 
proximity to c-Cbl. This is possibly the case with the C termini of Spry2, Met and EGFR 
peptides when compared with C termini of Spry4 and Syk, which bend away from the c-Cbl's 
surface and are therefore unaffected. In contrast, binding was retained for all of the WT proteins 
with the c-Cbl E334A mutant, suggesting that the binding mediated by this residue is not 
essential. 
Finally, to ensure that the structural changes created in the c-Cbl mutants did not 
influence c-Cbl's interaction with other proteins C-terminal to the TKB, such as Grb2 which 
binds via its SH3 domain to c-Cbl's proline-rich region, binding of these mutants to Grb2 was 
tested.  The results confirmed that binding to Grb2 was unaffected by the mutations created in 






2.3.10 Isothermal titration calorimetry reveals that Spry2 has the highest binding affinity 
to Cbl-TKB 
 To validate the necessity of the intrapeptidyl H-bond, it was examined whether binding 
can still occur in proteins that lack either the (pY-2)Asn or the adjacent Arg, as well as the 
relative contributions to binding made by the conserved residues in the consensus motifs. The 
binding affinities of nine 13-mer phosphopeptides were determined by titration against the Cbl-
TKB domain in isothermal titration calorimetry (ITC) experiments (Table 2.3): six sequences 
from the PTK subgroup (Spry2, Spry4, EGFR, Src, Syk, p75 NTR and VEGFR), with the 
exception of Spry2, other sequences lacking at least one of the conserved residues, the APS 
sequence and two sequences belonging to the Met subgroup (Met and Ron). Importantly, 
although the binding affinity for APS differed from that previously reported by Hu and Hubbard 
(2005) who used a pH 8.0 for their measurements, when the measurements were repeated 
measurements at pH 8.0 instead of pH 7.0, our findings replicated Hu and Hubbard's findings 




Table 2.3.  Sequence, affinity and favourability of the c-Cbl TKB binding motifs. 
Peptide Sequence  N  Ka  









Spry249-61  IRNTNEpYTEGPTV 0.920 ± 0.007 3.11 ± 0.25 0.32 -13.44 ± 0.14 -4.663 -8.777 
APS623-632 RAVENQpYSFY 1.010 ± 0.007 2.54 ± 0.20 0.39 -  6.44 ± 0.07  2.217 -8.653 
Spry447-59 SHVENDpYIDNPSL 1.060 ± 0.007 1.65 ±0.09 0.61 -  5.11 ± 0.05  3.276 -8.386 
EGFR1063-1075 DSFLQRpYSSDPTG 0.993 ± 0.01 1.14 ± 0.11 0.88 -  9.11 ± 0.15 -0.871 -8.242 
Src413-425 LIEDNEpYTARQGA 0.969 ± 0.01 0.756 ± 0.055 1.32 -  6.33 ± 0.11  1.612 -7.939 
Syk317-329 TVSFNPpYEPELAP 0.969 ± 0.01 0.673 ± 0.066 1.49 -  3.07 ± 0.08  4.811 -7.882 
Ron1011-1023 LYSGSDpYRSGLA 1.000 ± 0.01 0.644 ± 0.056 1.55 -  1.58 ± 0.03  6.257 -7.835 
Met997-1009 SNESVDpYRATFPE 1.080 ± 0.03 0.424 ± 0.053 2.36 -  1.60 ± 0.06  5.991 -7.593 
 
Met997-1009 D1002R, R1004D SNESVRpYDATFPE 1.02 ± 0.01 0.436 ± 0.022 2.29 -  1.09 ± 0.02  6.522 -7.612 
        
APS623-632 pH 8.0 RAVENQpYSFY 0.911 ± 0.002 18.4 ± 1.1 0.054 -10.96 ± 0.04 -1.071 -9.889 
EGFR1063-1075 pH 8.0 DSFLQRpYSSDPTG 0.991 ± 0.004 2.97 ± 0.12 0.336 -  6.178 ± 0.03  2.603 -8.781 
        
VEGFR1327-1338 YNSVVLpYSTPPI 0 0 0 0 0 0 
VEGFR1327-1338 V1331N YNSVNLpYSTPPI 1.050 ± 0.002 3.01 ± 0.09 0.33 -  5.003 ± 0.02 3.748 -8.751 
VEGFR1327-1338 L1332R YNSVVRpYSTPPI 0.997 ± 0.003 1.38 ± 0.04 0.72 -  3.238 ± 0.02 5.047 -8.285 
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(A) ITC at pH 7.0, 200mM NaCl 
  
Spry2                                                   APS                                                     Spry4 
 
 




                                 Ron                                                    Met                                      Met D1002R / R1004D 
 
 










(B) ITC at pH8.0, 100mM NaCl (reproducing data of Hu and Hubbard, 2005) 
 
                                                         APS                                                  EGFR 
 





Fig. 2.10.  The binding affinities of phosphorylated Spry249–61, APS623–632, Spry469–81, EGFR1063–1075, Src413–425, 
Syk317–329, Met997–1009, Met997–1009 D1002R / R1004D, Ron1011–1023, VEGFR1327–1338, VEGFR1327–1338 V1331N and 
VEGFR1327–1338 L1332R phosphopeptides to the c-Cbl-TKB domain were measured by ITC and profiles shown 
respectively (Ng et al., 2008). The figures show the injection profile after baseline correction and the bottom panels 
show the integration (heat release) for each injection (except the first one). The solid lines in the bottom panel show 
the fit of the data to a function based on a one-site binding model. The binding constants (Ka and Kd), number of 
binding sites (N), enthalpy (∆H) and entropy (ΔS) changes of Cbl-TKB to the various peptides are provided in 
(Table 2.3).  ITC experiments for APS623–632 and EGFR1063–1075 were also repeated at pH 8.0 according to Hu and 
Hubbard (2005). Non-phosphorylated Spry249–61 was titrated against Cbl-TKB as a negative control.  The 




 Of the nine peptides examined, binding between the Cbl-TKB and the phosphorylated 
Spry2 peptide occurred with the highest affinity and the most negative Gibbs free energy change 
(Table 2.3), suggesting that this reaction is most favoured. In descending order of affinity, the 
dissociation constants (Kd) were as follows: Spry249–61(0.32μM) > APS623–632 (0.39μM) > 
Spry469–81(0.61μM) > EGFR1063–1075 (0.88μM) > Src413–425 (1.32μM), Syk317–329 (1.49μM), 
Ron1011–1023 (1.55μM) and Met997–1009 (2.36μM); the latter four were not significantly different 
from each other.  Strikingly, the phosphorylated VEGFR11327–1338 that did not possess a 
conserved (pY-2)Asn or (pY-1)Arg and was unable to bind Cbl-TKB, supporting our hypothesis 
that the intrapeptidyl H-bond is essential for binding to the Cbl-TKB domain.  The ITC profiles 
are shown in Fig. 2.10.     
 When comparing between the (pY-2)Asn and the adjacent Arg, it was observed that the 
Asn residue provides a greater contribution to binding affinity, as demonstrated by Spry2 versus 
EGFR, both of which contain the other three conserved residues, and by Src versus Ron/Met, 
which only have one other conserved residue. A degenerate peptide library characterization of 
the (D/N)XpY(S/T)XXP motif indicated that the most favourable residues for binding N-
terminal of pTyr are: (pY-2)Asn, (pY-2)Asp or (pY-3)Asp (Liu et al., 2002). Surprisingly, an 
Arg residue N-terminal of pTyr was not significantly selected for binding. It is likely that there is 
no preference for Arg at the pY-1 position, because an Asn provides higher affinity binding and, 
as their roles overlap in this context, an Asn at the pY-2 position will be preferred. 
 Contributing next to the binding affinity is the (pY+4)Pro residue, as shown by the higher 
affinity of EGFR compared with Met and Ron, and the higher affinity of Spry2 compared with 
Src and Syk. APS, whose affinity is just below Spry2, also lacks the (pY+4)Pro, but appears to 
compensate for this by using other conserved residues N-terminal to the pTyr to enhance 
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binding. Interestingly, the extent of the hydrophobic interaction between the (pY+4)Pro and its 
corresponding cleft on Cbl-TKB was directly correlated with the peptide's affinity for the latter: 
hydrophobic interaction was most extensive with Spry2 at this cleft, followed by Spry4 and, to a 
lesser extent, EGFR. The conserved (pY+1)Ser/Thr appears to contribute least to the binding 
affinity, as suggested by the insignificant differences in affinity between Src and Syk. All of 
these results support the variations in binding we observed with the full-length proteins. 
 The (pY-1)Asp of Ron and Met does not appear to contribute substantially to binding 
affinity, as these peptides have no significant differences in affinities with Syk, which has no 
additional residues other than the (pY-2)Asn. Interestingly, most of the interactions between Met 
and c-Cbl are mediated by the DpYR residues. The side chain of the (pY-1)Asp binds to the 
Tyr274 of Cbl-TKB, whereas in other complexes, this interaction is mediated by the backbone of 
the pY+1 residue (Table 2.3). Since the Met D1002A mutation cannot bind to c-Cbl (Peschard et 
al., 2004), and since the Cbl Y274F mutant cannot bind to Met, this may indicate why the Asp 
residue in the Met family of proteins has been conserved. 
 
2.3.11 The intrapeptidyl H-bond is essential for binding to the TKB domain 
 To further validate the importance of the intrapeptidyl H-bond, two mutant 
phosphorylated peptides for VEGFR1 harbouring Asn or Arg substitutions were included.  These 
mutations would permit formation of an intrapeptidyl H-bond and facilitate binding if these 
amino acids were the key requirement for binding: (1) VEGFR1 with a Val1331Asn substitution 
at the pY-2 position, and (2) VEGFR1 with a Leu1332Arg substitution at the pY-1 position. This 
substitution would also endow VEGFR1 with four conserved residues, and it would therefore be 
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expected to bind with similar affinities to Spry2 and EGFR, respectively. Indeed, both of these 
substitutions facilitated peptide binding to the Cbl-TKB domain (Fig. 2.10) and, as expected, 
binding affinities were similar to Spry2 and EGFR (0.33 and 0.72μM respectively) were 
observed (Table 2.3). These findings confirm the requirement for the formation of an 
intrapeptidyl H-bond between pTyr and (pY-2)Asn or an adjacent Arg at the pY-1 or pY+1 
position when reversed, and also substantiate the greater contribution of Asn towards a 
substrate's affinity for Cbl-TKB. 
 
2.3.12 Inversion of the DpYR motif in Met preserves binding 
 The finding that Met binds to Cbl-TKB in a reverse orientation, with (pY+1)Arg 
replacing the role of (pY-2)Asn to form an essential hydrogen bond with phosphotyrosine, lead 
to the hypothesis that the Met peptide would still be able to bind Cbl-TKB if the DpYR motif 
was flipped to RpYD, provided that the adjacent residues do not pose any steric hindrances.  
Indeed, ITC of phosphorylated Met997-1009 D1002R / R1004D shows that the binding affinity of 
this Met double mutant was not significantly different from the wild type Met997-1009 sequence 
(Table 2.3), suggesting that residues flanking the DpYR motif are not necessary for binding to 








 The aim of this study was to address two major questions: (1) Why does the TKB domain 
recognize an unusually broad set of sequence-recognition motifs and (2) could variations in the 
binding affinity of TKB domain-binding proteins result in the selective sequestration of c-Cbl by 
higher-affinity binding proteins. In addressing the latter, results suggest that differences in 
binding affinity do exist between different TKB-binding proteins.  We cannot confirm, however, 
whether the sequestration of c-Cbl is physiologically important. Given a favourable cellular 
localization, it is possible that Spry2 with its higher binding affinity, could influence the binding 
of c-Cbl to particular RTKs (e.g. EGFR) or other TKB-binding proteins. In addressing the first 
question, two novel and unexpected elements have been revealed: (1) binding is essentially 
achieved through (D/N)XpY, RpY or pYR (in the reverse orientation) through the formation of 
an intrapeptidyl H-bond, and (2) the Cbl-TKB domain can bind to substrates in two orientations. 
The unique diversity of the TKB domain in its recognition of three consensus sequences 
is an unusual characteristic for an SH2 domain. These five complexes demonstrate some 
consistency in binding between the Cbl-TKB targets, and together indicate that the TKB domain 
recognizes a less-radical set of motifs. The intrapeptidyl H-bond between pTyr and (pY-2)Asn, 
(pY-1)Arg or (pY+1)Arg in the reverse is necessary for the directed, 'hand-in-glove' fit of the 
peptide into a positively charged pocket of the SH2 region of the Cbl-TKB domain (depicted in 
Fig. 2.11A–D for Spry2 and Met), whether before binding to c-Cbl or concomitantly. Although 
this intrapeptidyl H-bond was identified in both of the previously characterized c-Cbl structures 
(Meng et al., 1999; Hu and Hubbard, 2005), proper consideration was not attributed to it due to a 
lack of supporting evidence to highlight its significance. When combined with these five 
structures, we are able to assign importance to the intrapeptidyl H-bond as a rule for binding and 
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an event crucial for the directed positioning of the substrate on c-Cbl. Furthermore, with the ITC 
characterizations of the three VEFGR peptides, we show convincing evidence that binding to c-
Cbl cannot occur without this intrapeptidyl H-bond, despite the presence of other conserved 
residues (depicted with a model diagram in Fig. 2.11E–G).    These other conserved residues—
(pY+1)Ser/Thr, (pY+4)Pro and (pY-1)Asp—tweak the binding affinity, and such as in the case 
of APS, high-affinity binding can be compensated for by these other residues. Substrate binding 
is further stabilized in concert with the 4H subdomain and EF-hand, particularly the 4H 
subdomain, which contributes to binding via the Pro81 residue to the conserved (pY-2)Asn or 
compensating Arg (Fig. 2.11), and structural evidence suggests that these sub-domains form an 
intimate, multifaceted association with the SH2 subdomain, linker sequence and RING domain 






Fig. 2.11.  Orientation of the intrapeptidyl hydrogen (H) bond within the binding pocket of the Cbl-TKB (Ng et al., 
2008). A cross-sectional perspective of the binding topograph in Figure 2B and F illustrates the fit of the 
phosphopeptides on the surface of the Cbl-TKB domain for (A) Spry249–61 (cyan) and (B) Met997–1009 (pink). (C, D) 
Peptides superimposed from two different angles. (E–G) Schematic diagrams illustrating the importance of the 
intrapeptidyl H-bond between pTyr and (E) (pY-2)Asn for Spry2 or (F) (pY+1)Arg for Met in the reverse 
orientation. In the absence of an intrapeptidyl H-bond (G), pTyr is disorientated and unable to dock into the pTyr-
binding pocket on Cbl-TKB, as indicated by VEGFR. 
 
A comprehensive search of the known SH2 domain structures available in the protein 
data bank resulted in only four complex models where a pTyr formed a H-bond with the side 
chain of another residue in the peptide (Gunther et al., 2003; Cho et al., 2004; Frese et al., 2006). 
For the first case, the H-bond was not conserved among the different peptides complexed with 
the SH2 domain of Gads (Cho et al., 2004). In the Nck1-SH2:phospho-Tir and Nck2-
SH2:phospho-Tir complexes, a degenerate peptide library scan showed a preference for 
hydrophobic residues over the interacting His at that position (Frese et al., 2006). The last 
complex model between the SH2 domain of PI3 kinase and the phospho-platelet-derived growth 
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factor receptor peptide identified the preference for negatively charged residues N-terminal to the 
pTyr that were not essential for binding nor bound to its SH2 domain in the same manner as the 
conserved (pY-1)Asp binds to the TKB domain of c-Cbl in the Met family of proteins (Gunther 
et al., 2003). 
Similarly, a search performed on known structures of PTB-binding peptides bearing the 
conserved D/NXpY and complexed with PTB domains also revealed that none of these binding 
conformations had the signature H-bond between the pTyr and the (pY-2)Asn. To the best of our 
knowledge, there are no conserved intrapeptidyl H-bonds between pTyr and its neighbouring 
Asn/Arg residues for SH2 and PTB domain-binding proteins. The formation of the intrapeptidyl 
H-bond in the D/NXpY, RpY or pYR (in the reverse) motifs is likely to be an essential 
specificity determinant for the recognition and docking of c-Cbl to its activated (phosphorylated) 
target proteins, whether before or during binding, and thus represents a mechanism that is unique 
to Cbl. 
The most surprising finding from the crystal structure analyses is the reversed binding of 
the Met phosphopeptide. From these results, it would be presumed that other members of the 
Met subgroup also bind in the reverse direction. Interestingly, many of these family members 
have a proline residue at the pY-4 position (Fig. 1.14), which would align with the (pY+4)Pro 
residue in members of the PTK subgroup in the reverse orientation, and presumably increase 
their binding affinity to c-Cbl over Met. 
There are several analogous situations where ligand binding can occur in two orientations 
of a specific domain. The SUMO-binding amino-acid sequence motif of RanBP2 and PIASX-P 
have been shown to bind to the surface of SUMO-1 in two different orientations (Reverter and 
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Lima, 2005; Song et al., 2005) and similarly, the SH3 domain of Src can bind to proline-rich 
peptide ligands in two orientations (Feng et al., 1994). Furthermore, the PH domain of ArhGAP9 
accommodates both PI(3,4)P2 and PI(4,5)P2 at 180° rotations via a shallow, noncanonical 
binding pocket (Ceccarelli et al., 2007). To our knowledge, however, there is no precedent for an 
SH2-domain-binding protein to bind to an SH2 domain in two orientations, and raises the 
question whether this may also occur. However, as the TKB domain accomplishes binding in 
conjunction with the 4H subdomain, its absence in other SH2 domains may restrict them from 
having such flexibility of binding. 
The reverse binding of Met and the previously unidentified importance of the (pY-1)Arg 
in EGFR suggests that there is a larger cohort of Cbl-TKB domain targets, particularly those with 
an RpYD or RpYS/T motif. Searching the human proteome, nearly 300 signal transduction 
proteins containing the RYD sequence have been identified, and while it still remains to be 
determined whether these proteins are substrates for c-Cbl, this emphasizes the likelihood that 
other unrevealed c-Cbl targets exist. In addition, the reversed binding of Met may reflect the 
need for Cbl to bind to targets in two orientations for steric reasons, as the DpYR residues in Met 
lie very close to the plasma membrane in the juxta-membrane domain. This reversed binding 
presumably allows the appropriate distance for the subsequent ligation of ubiquitin moieties. In 
contrast, the reversed binding may also allow c-Cbl to bind to proteins without resulting in their 
ubiquitination, expanding Cbl's role as an adapter protein in signalling complexes other than the 
APS family of proteins. Together, these findings provide not only further clues to Cbl's role in 
signalling but also the incentive to revisit previously identified binding motifs of other proteins, 








CaM Regulation of  











 The regulation of VGSC by CaM was surprising but not unprecedented, as CaM appears 
to be an important regulator of several different ionic currents.  Saimi and Cheng (2002) 
proposed that CaM itself could be considered a channel subunit.  Interestingly, all previous 
accounts of Ca2+ influence on ion channels involve proteins that modify but are not directly 
involved in generating and propagating the action potential.  The association of CaM for VGSC 
is the first description of such a basic and essential channel for the action potential being 
regulated by Ca2+.  Furthermore, all VGSC isoforms possess the conserved IQ domain for CaM 
binding, but are not regulated in the same way (Deschenes et al., 2006).  Although the common 
feature is coupling to cytoplasmic Ca2+ regulation, it is not understood why the need for certain 
VGSCs to be Ca2+ dependent. 
In the early 1990s, a model was proposed in which an auto-inhibitory domain becomes 
displaced from the active site upon binding of CaM, leading to the activation of the enzymes.  
However, with the determination of an increasing number of CaM-complex structures, it became 
evident that there is no general model for binding, since each complex represent a different 
binding mode (Vetter and Leclerc, 2003).  Using two VGSC isoforms from skeletal muscle and 
neurons, Nav1.4 and Nav1.6 respectively, we propose to characterize and compare the 
association of CaM with these IQ motifs of high sequence identity.  This will be towards 
understanding (1) the mechanism by which VGSC IQ motifs bind to CaM but retain flexibility to 
regulate the Na+ current in different ways, and (2) how differences in binding affinity translate to 




3.2 Method and Material 
3.2.1 Plasmid constructs, cloning and expression 
Wild type full length mouse (Mus musculus) Calmodulin isoform 1 (CaM) cDNA was 
cloned into pET3a plasmid (Novagen, Darmstadt, DE) between NdeI and BamHI restriction 
sites. Recombinant CaM was overexpressed in Escherichia coli expression host strain 
BL21(DE3) and purified according to Hayashi et al., 1998 with modifications. The purified 
protein (1 mg/ml) was stored in buffer A (50mM Tris-HCl pH 7.5, 1mM CaCl2) and used for 
crystallization and ITC experiments. 
E88A and E128A mutations on CaM were performed according to Wang and Malcolm, 
1999.  Both mutants were expressed in E. coli and purified similar to wild type CaM. 
Mouse neuronal VGSC subtype Nav1.6 cytoplasmic domain (ΔNav1.6) corresponding to 
residues 1517-1687 was inserted into pET25b (Novagen, Darmstadt, DE) between NdeI and 
XhoI restriction sites.  Recombinant ΔNav1.6 was expressed as a His-tagged fusion protein (His-
ΔNav1.6) in BL21(DE3) (GE Healthcare, Buckinghamshire, UK) and purified from inclusion 
bodies according to the protocol established by Oganesyan et al., 2005. 
 
3.2.2 Isothermal titration calorimetry 
Nav1.4IQ and Nav1.6IQ were titrated against 1mM CaM in a VP-ITC microcalorimeter 
(Microcal, Northampton, UK) in the high and low Ca2+ concentrations. The peptides were 
reconstituted in buffers A and C at 22°C and titrated in 10 μl injections into CaM maintained in 
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the respective buffers. The heat of dilution was determined by titrating peptide into buffer in a 
separate experiment and subtracted from the raw data before curve fitting and refinement. The 
dissociation constants of Cbl-TKB to the various peptides were determined by least squares 
method and the binding isotherm was fitted using Origin v7.0 (Microcal) assuming a single-site 
binding model. All measurements were repeated at least twice for verification. 
 
3.2.3 Computational modelling  
 In parallel to co-crystallisation experiments, the structures of Nav1.4IQ and Nav1.6IQ in 
complex with Ca2+/CaM were modelled using DeepView (Guex and Peitsch, 1997).  The initial 
template model was derived from a 2.0Å crystal structure of the Cav1.2 IQ domain – Ca2+
 
/CaM 
complex, pdb code 2BE6 (Petegem et al., 2005).  Positions of the side-chains were refined by 
energy minimisation.   
3.2.4 Complex formation and crystallization 
IQ domain peptides of mouse Nav1.4 1719-1742 (Nav1.4IQ) and Nav1.6 1645-1668 
(Nav1.6IQ) (Sigma Genosys) were reconstituted in buffer A and buffer C and incubated with the 
purified CaM in two-fold molar excess at room temperature for 1 h for complex formation. The 
CaM: peptide complexes were concentrated to 20mg/ml and CaM: His-∆Nav1.6 concentrated to 
5mg/ml using an Amicon Ultra ultrafiltration devices (Millipore, Billerica, MA). These 
complexes were screened for crystals using commercial screen kits from Hampton Research, 
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CA, Qiagen, NL and Jena Biosciences, DE using hanging drop vapour diffusion and under oil 
methods respectively.  Initial crystallization conditions were optimised by varying precipitant or 
additive concentrations.   
The crystals of Nav1.6IQ: Ca2+
 
/CaM complex were tested and a partial dataset was 
collected with a Platinum135CCD detector mounted on a Microstar-H rotating anode x-ray 














3.3.1 Cloning of CaM, ΔNav1.6 
 Mouse CaM (447bp) and ΔNav1.6 (510bp) cDNAs were isolated from whole mouse 
brain by RT-PCR.  Total RNA from whole mouse brain was extracted using Trizol reageant 
(Invitrogen, California, USA), from which the first strand of total brain cDNAs were synthesized 
from mRNA using oligo-dT primer.  CaM and ΔNav1.6 cDNAs with flanking restriction enzyme 
cut sites were amplified by PCR using their respective primers (Fig. 3.1). 
 
  
(A)                                    (B)               
                                     
Fig. 3.1.  PCR amplification of (A) CaM and (B) ΔNav1.6 cDNAs.  RT-PCR was used to clone CaM and ΔNav1.6 
from mouse brain, yielding fragments of approximately 450bp and 510bp that correspond to the molecular weights 
of these two genes. 
 
 The 450bp and 510bp fragments were gel-purified and digested with NdeI / BamHI and 











































































ligation clones were screened by colony PCR, and the correct DNA sequence verified by gene 
sequencing (Fig. 3.2). 
 
  
(A)               (B)        
 
Fig. 3.2.  Colony PCR of ligated and transformed (A) CaM and (B) ΔNav1.6 clones.  The inserted genes of interest 
were amplified using vector primers pair T7 promoter / T7 terminator flanking the multiple cloning sites.  The 
amplified fragments were thus approximately 150bp and 260bp larger than the inserted genes respectively, which 
correspond to the approximately 600bp fragment observed in (A) and 770bp fragment observed in (B). 
 
3.3.2 Expression of ΔNav1.6 and association with CaM 
The cloned ΔNav1.6 was transformed into Escherichia coli expression strain 
BL21(DE3).  100ml of Luria-Bertani (LB) media supplemented with 100μg/ml ampicillin was 
inoculated with one colony of BL21(DE3)(pET25b- ΔNav1.6) and grown overnight at 37ºC with 
aeration.  The overnight culture was amplified to 1L and protein expression induced with 0.1mM 
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 His tagged ΔNav1.6 (His-ΔNav1.6) was harvested by six cycles of 1min sonication with 
40s interval between cycles.  Most His-ΔNav1.6 expressed as inclusion bodies and was pelleted 
in the insoluble fraction.  ΔNav1.6 was successfully purified to homogeneity from the insoluble 
fraction by 8M urea denaturation and refolding according to the method described by Oganesyan 




Fig. 3.3.  12.5% SDS-PAGE purification profile of His-ΔNav1.6 purified by 6M urea denaturation and refolding 
being visualized by Coomassie staining.   
 
The eluted His-ΔNav1.6 from Ni-NTA was stable without any visible precipitate even 
after a week.  It was further purified by using a Superdex-G200 (GE Healthcare, 
Buckinghamshire, UK) gel filtration column.  His-ΔNav1.6 eluted as a homogeneous monomeric 

















































































Fig. 3.4.  Gel filtration profile of His-ΔNav1.6 in a 120ml column volume Superdex-200 column.  His-ΔNav1.6 was 
purified to homogeneity by gel filtration and eluted in buffer A+100mM NaCl and 10mM βME.  Blue plot indicate 
His-ΔNav1.6 gel filtration profile, grey line is gel filtration molecular size standard with molecular weight of the 
peaks labeled (BioRad, CA). 
 
3.3.3 Expression and purification of CaM 
The cloned CaM was transformed into Escherichia coli expression strain BL21(DE3), 
expressed and harvested the same way as His-ΔNav1.6.  CaM was purified by a phenyl-
sepharose column (GE Healthcare, Buckinghamshire, UK) according to the Hayashi et al., 1998 
protocol.  Further purification was achieved by using Superdex-G75 (GE Healthcare, 
Buckinghamshire, UK) gel filtration column.  Purified CaM eluted as a single monomeric peak 









salt, CaM behaved as a trimer and eluted at an approximate peak volume of 64mL from the same 
column (Fig. 3.5C).   
 
 










(B) 12.5% SDS-PAGE purification profile of CaM 
 
 
       
(C) Gel filtration profiles of purified CaM 
 




















































































































(II) CaM elution without NaCl 
 
Fig. 3.5.  Purification and preliminary characterization of CaM.  (A) Phenyl-sepharose purification profile of CaM.  
(B) Samples were obtained at different stages of purification and separated in 12.5% SDS-PAGE.  CaM eluted with 
little impurity phenyl-sepharose and was purified to homogeneity by gel filtration superdex G-75, migrating as an 
approximately 17kDa band.  (C) Eluted CaM was applied to Superdex-G75 gel filtration column and eluted as a 
single peak of monomeric species in 100mM NaCl (I) but as a trimer in the absence of NaCl (II). Red plot represents 
gel filtration profile of CaM in buffer A, while blue plot represents CaM elution profile in buffer C.  The CaM peak 
is indicated by black arrows. 
 
 
3.3.4 Pull down assays and gel filtration confirm Nav1.6 binds to CaM 
In order to ascertain if VGSC binds to CaM in vitro, resolubilised His-ΔNav1.6 was used 
as a representative of the two isoforms (Nav1.4 and Nav1.6) that share high sequence similarity 
(54% sequence identity and 80% sequence similarity) in the IQ motif.  His-ΔNav1.6 was divided 
into two batches of identical protein concentration and bound to CaM-Sepharose (GE 
Healthcare, Buckinghamshire, UK).  One batch was bound and rinsed in buffer A with 100mM 
NaCl and the other batch in buffer C with 100mM NaCl.  His-ΔNav1.6 in high Ca2+ 
concentration (buffer A) showed greater binding to CaM, as indicated on SDS-PAGE (Fig. 














Fig. 3.6.  12.5% SDS-PAGE purification profile of His-ΔNav1.6 trapped by CaM-sepharose in (A) high Ca2+ 















































































































































































































binding affinity of His-ΔNav1.6 for CaM-speharose, shown by the ability of the latter to retain His-ΔNav1.6 in 
buffer A but not buffer C. 
 
 Purified His-ΔNav1.6 was further incubated with Ca2+/CaM in a 1:1 molar ratio and 
applied to Superdex-G200.  The complex was eluted as a single peak at 83mL, which 
corresponds to a 1:1 His-ΔNav1.6: CaM complex ratio that is approximately 40kDa in size (Fig. 
3.7).   
 
Fig. 3.7.  Superimposed elution profiles of His-ΔNav1.6 (red), Ca2+/CaM (Blue) and His-ΔNav1.6:Ca2+/CaM 
complex (green) from Superdex-G200.  His-ΔNav1.6 was mixed in a 1:1 ratio with Ca2+/CaM in buffer A + 






3.3.5 Isothemal titration calorimetry reveals that binding affinity is stronger in the 
presence of Ca2+ and NaCl 
 Unfortunately, binding affinity of CaM for ΔNav1.6 by ITC was unobtainable as the 
domain was insoluble at high concentrations required for ITC experiments. The binding affinities 
and influence of NaCl on VGSC isoforms IQ motif for CaM were therefore further determined 
by titrating the interacting peptides derived from Nav1.4IQ and Nav1.6IQ  against 50μM purified 
CaM in the presence and absence of NaCl, along with high and low concentrations of Ca2+.   
Of the two peptides examined, Nav1.6IQ bound to CaM in a 1:1 ratio at a single binding 
site.  The binding affinity of Nav1.6IQ for apoCaM and Ca2+/CaM is the same in the absence of 
NaCl (Fig. 3.6B) but Nav1.6IQ exhibits approximately seven-fold stronger binding to Ca2+/CaM 
compared to apoCaM and a more negative Gibbs free energy change in the presence of 100mM 
NaCl.  These observations may be attributed to the differences in the structure of monomeric 
apoCaM and Ca2+/CaM (Fig. 1.8; Vetter and Leclerc, 2003).  However, when compared to its 
affinity in the absence of NaCl, binding of the IQ motif is still weaker than in the presence of 
NaCl. 
Unlike Nav1.6IQ, the association of Nav1.4IQ for CaM was more complex.  Binding 
kinetics for apoCaM and Ca2+/CaM changed drastically in the presence and absence of NaCl.  
apoCaM bound to Nav1.4IQ in a 1:1 ratio that was readily fitted with a single site binding model 
only in the presence of NaCl, in a manner similar to Nav1.6IQ.  In the absence of NaCl, the 
binding of apoCaM to Nav1.4IQ changed to adopt a complex pattern of two events that was 
reproducible and consistent over many experimental repeats – (1) a high affinity, exothermic 
reaction largely driven by enthalpy of 1:1 binding ratio, and (2) a lower affinity, endothermic and 
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entropy driven reaction where only a third of the CaM sites were occupied, possibly due to the 
trimeric nature of CaM without NaCl.  Notably reminiscent of Nav1.6IQ, the second yielded 
affinities and Gibbs free energy changes that were not significantly different from Ca2+/CaM: 
Nav1.4IQ without salt. We thus conclude that the second reaction is the association of Nav1.4IQ 
to apoCaM.   
In the presence of NaCl, the Ca2+/CaM: Nav1.4IQ reaction does not tend to saturation 
even when peptide to CaM ratio was increased during titration.  This incomplete binding is 
indicated by the large ΔH pleateau (~ -0.15 ucal/s) that is not caused by the heat of dilution 
(~0.04ucal/s) (Fig. 3.8A and C).  However, as with Nav1.6IQ, affinity calculations still indicate 
that Ca2+/CaM: Nav1.4IQ binding is tighter than apoCaM/Nav1.4IQ in the presence of NaCl.  In 
the absence of NaCl, incomplete binding was also present but not as pronounced for Ca2+/CaM: 
Nav1.4IQ. 
From the above discussed ITC results, the following conclusions can be drawn: (1) when 
NaCl is present, both peptides bind more strongly to Ca2+/CaM than to apoCaM, (2) when NaCl 
is absent, the binding affinity of Nav1.6IQ for apoCaM and Ca2+/CaM is the same, but (3) the 
binding dynamics of Nav1.4IQ changes.  The ability of NaCl to influence binding indicates that 
hydrogen bonds or charge-charge interactions play an important role in the interactions between 






(A)  ITC in 100mM NaCl (monomeric CaM) 
Cell  Ligand  N  Ka  









ApoCaM  Nav1.4IQ 1.08   ± 0.0043 0.650 ± 0.032 1.53 -  2.937 ± 0.016  4.899 -7.836 
 
 
Nav1.6IQ 1.03   ± 0.0042 0.121 ± 0.0025 8.26 -10.320 ± 0.058 -3.453 -6.867  
Ca2+/CaM  Nav1.4IQ 0.994 ± 0.0048 1.690 ± 0.14 0.592 -  1.480 ± 0.010   6.936 -8.416 
 Nav1.6IQ 1.06   ± 0.0032 0.858 ± 0.033 1.17  -11.540 ± 0.047 -3.512 -8.028 
 
 













(B) ITC in no NaCl (trimeric CaM) 
Cell  Ligand  N  Ka  









ApoCaM  Nav1.4IQ N1: 1.03   ± 0.0052 
N2: 0.358 ± 0.057 
K1: 23.0     ± 8.2 
K2:   0.238 ± 0.068 
K1: 0.043 
K2: 4.20 
H1:-7.165 ± 0.021 
H2: 2.842 ± 0.63 






Nav1.6IQ 1.04   ± 0.0032 1.58   ± 0.083 0.633 -15.81 ± 0.071 -7.438 -8.372  
Ca2+/CaM  Nav1.4IQ 1.05   ± 0.011 0.248 ± 0.017 4.032 -  3.26 ± 0.046  4.044 -7.301 
 Nav1.6IQ 1.06   ± 0.0028 1.58   ± 0.054 0.633  -11.18 ± 0.041 -2.807 -8.373 
 
 
        apoCaM:Nav1.4IQ                                apoCaM:Nav1.6IQ                                 Ca2+/CaM:Nav1.4IQ                             Ca2+/CaM:Nav1.6IQ 
.   
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(C) ITC control by titrating Nav1.4IQ into buffer A + 100mM NaCl 
 
Fig. 3.8. The binding affinities of Nav1.4IQ and Nav1.6IQ peptides to CaM were measured by ITC (A) in 100mM 
NaCl, (B) without NaCl and (C) without CaM.  The profiles are shown respectively.  The binding constants (Ka and 
Kd), number of binding sites (N), enthalpy (∆H) and entropy (ΔS) changes of CaM to the various peptides are 
provided in the tables.  Figures below the tables show the injection profile after baseline correction and the bottom 
panels show the integration (heat release) for each injection (except the first one). The solid lines in the bottom panel 
show the fit of the data to a function based on a one-site binding model. Nav1.4IQ was titrated against buffer A + 
100mM NaCl as a negative control and for subtraction of the heat of dilution.  The concentration of the CaM was 
50μM in all experiments. 
 
3.3.6 Computational modelling and model verification by ITC 
 Motifs that interact with CaM generally assume an α-helix upon binding (Rhoads and 
Friedberg, 1997; Osawa et al., 1999).  Based on structural and computational analyses of IQ 
motifs from myosins and VGCCs in complex with CaM, it has been shown that the preferred 
conformation of the IQ motif is a seven-turn α-helix when bound to CaM (Hamilton et al., 2000; 
Fallon et al., 2005; Houdusse et al., 2006).  By combining literature and sequence analysis, we 
chose the 2.0Å structure of VGCC isoform 1.2 in complex with Ca2+/CaM (PDB code 2BE6) as 
the starting template to model Nav1.4 and Nav1.6 IQ motif peptide complexes with Ca2+/CaM.  
It is noteworthy that the VGCC shares the highest sequence similarity to the IQ motifs of Nav 
isoforms, and is a representative of an IQ motif from ion channel receptors.   The structures of 
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(B) Nav1.6IQ: Ca2+/CaM 
 
Fig. 3.9.  The inferred modelled structures of (A) Nav1.4IQ and (B) Nav1.6IQ with Ca2+/CaM showing potential 
hydrogen bonds that may govern binding.  CaM residues participating in hydroen bond interactions are grey 
coloured and labelled.  Hydrogen bonds are depicted as magenta dotted lines and the IQ motifs of Nav1.4 and 1.6 in 
green and cyan respectively.  Figure was prepared using Pymol (DeLano, 2002). 
 
 
 From the inferred models, most of the residues in the substrate binding cleft of CaM 
interact with both Nav1.4 and Nav1.6 peptides.  In particular, the side chains of Glu12, Glu88, 
Glu124 and Glu128 are in the vicinity of the peptide to form potential hydrogen bonding 







































(B) Nav1.6IQ: Ca2+/CaM 
 
Fig. 3.10.  Hydrophobic patches on CaM that form stacking interactions with (A) Nav1.4IQ and (B) Nav1.6IQ 
interacts with.  Hydrophobic patches are shown as transparent white surfaces.  The Nav1.4IQ peptide is green and 
the Nav1.6IQ peptide is cyan.  Figure was prepared by Pymol (DeLano, 2002). 
 
 
 To verify that the CaM: peptide models, two residues on CaM (E88, E128) whose side-
chains can potentially form hydrogen bonding contacts with Nav1.4IQ but not with Nav1.6IQ 
were chosen and mutated to Ala.  ITC results showed an alteration in the binding profiles of 
Nav1.4IQ for the mutants (Fig. 3.11A and B).  However, no significant change in binding 




             (A) Nav1.4IQ: Ca2+/E88ACaM                (B) Nav1.4IQ: Ca2+/E128ACaM 
 
  
             (C) Nav1.6IQ: Ca2+/E88ACaM               (D) Nav1.6IQ: Ca2+/E128ACaM 
 
Fig. 3.11.  The binding affinities of Nav1.4IQ and Nav1.6IQ peptides to CaM mutants were measured by ITC in 
bffer A. (A) Nav1.4IQ: Ca2+/E88ACaM, (B) Nav1.4IQ: Ca2+/E128ACaM, (C) Nav1.6IQ: Ca2+/E88ACaM, (D) 
Nav1.6IQ: Ca2+/E128ACaM.  The injection profiles are shown respectively baseline correction. Bottom panels show 
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the integration (heat release) for each injection (except the first one). The solid lines in the bottom panel show the fit 
of the data to a function based on a one-site binding model. The concentration of CaM was 50μM in all experiments. 
 
 
 Our ITC studies on the CaM mutants clearly indicate that the inferred models are reliable.  
The observed change in the binding affinity with Nav1.4IQ could be a result of disrupting the 
formation of potential H-bonds between the peptide and CaM.  However, Nav1.6IQ still binds 
with CaM because Glu88 and Glu128 do not participate in any hydrogen bonding contact with 
CaM.  In order to further validate our results, we are currently in the process of obtaining co-
crystal structures of these complexes. 
 
3.3.7 Crystallization  
  In order to confirm the Nav1.4IQ: and Nav1.6IQ: Ca2+/CaM inferred models and 
elucidate their mechanism action, the IQ motif peptides are presently being co-crystallised with 
CaM.  Complex crystal structures will help in understanding the differences in binding dynamics 
between the VGSC isoforms for CaM.  To this end, Ca2+/CaM was concentrated to 18mg/ml and 
incubated with two-fold molar excess of Nav1.4IQ and Nav1.6IQ peptides separately.  
Ca2+/CaM was also incubated with His-∆Nav1.6 in a 1:1 molar ratio and concentrated to a 
maximum concentration of 5mg/ml. The crystallisation screen was performed by mixing 1μl 
protein with 1μl mother liquor and equilibrated against 500μl reservoir solution using hanging 
drop vapour diffusion method.  No crystals were obtained from commercial screen kits such as 
Hampton Research, Qiagen and Jena Biosciences.  Analysis of all the crystallisation drops 
showed that the protein remained soluble in most 2-Methyl-2,4-pentanediol (MPD) conditions.  
When compared with the conditions of previously crystallised CaM complexes, the MPD 
concentrations in commercial screen kits were at least 20% lower.  Since the calculated pI of 
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CaM is approximately 4.5, the CaM: Nav1.4 and Nav1.6 complexes were further screened in 
specially prepared conditions with pH varied from 3.0 to 6.5 and MPD concentrations between 
45 to 65% v/v.   
Initially, needle shaped crystals of Nav1.4IQ, Nav1.6IQ: Ca2+/CaM and His-∆Nav1.6: 
Ca2+/CaM were obtained from a condition containing 0.1M sodium acetate pH 4.5, 65% MPD 
and 20mM CaCl2 at 4°C.  These crystals were too small to be diffracted (Fig 3.12).  Further 
optimisation marginally improved the crystal quality. Nav1.4IQ: Ca2+/CaM complex crystals 
grew in 0.1M Bis-Tris pH 5.5, 65% MPD and 20mM CaCl2 (Fig. 3.13) and is currently being 
optimised. 
 
      






Fig. 3.12.  Initial crystals from the screening of Nav1.4IQ: Ca2+/CaM, Nav1.6IQ: Ca2+/CaM and His-∆Nav1.6: 




      
                          Nav1.4IQ: Ca2+/CaM                                                              Nav1.6IQ: Ca2+/CaM 
 
Fig. 3.13.  Current crystals of Nav1.4IQ: Ca2+/CaM and Nav1.6IQ: Ca2+/CaM obtained after grid optimization by the 
hanging drop vapour diffusion method.  Crystals of Nav1.4IQ: Ca2+/CaM could not be diffracted; those of 
Nav1.6IQ: Ca2+/CaM as indicated by the red arrows were used for diffraction.  These crystals were cryo-protected 
using mother liquor and flash frozen in liquid nitrogen before data was collected. 
 
 Similarly, crystals of the Nav1.6IQ: Ca2+/CaM complex were optimised with a reservoir 
solution of 0.1M sodium acetate pH 4.5, 55% MPD, 20mM CaCl2 and 8% n-propanol.  These 
crystals diffracted to 3.3Ǻ (Fig. 3.15), and a partial dataset was collected.  This crystallisation 
condition currently being optimised to improve crystal quality.  To verify whether the presence 
of CaM: Nav1.6IQ peptide complex in the crystals, several crystals were collected from drops 
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and extensively washed in reservoir solution prior to its separation in a 16% SDS-PAGE under 
denaturing conditions.  The crystals migrated as two bands, one corresponding to CaM’s 
molecular weight of 16.8kDa and the other band smaller than the 6kDa band of a protein 
molecular weight standard (Biorad), presumably the Nav1.6IQ peptide which is approximately 
3kDa (Fig. 3.14).  Smearing of the lower molecular weight bands in the protein marker and 
sample lanes are most likely to be caused by the low percentage gel for this peptide.  Higher 
percentage gels could not be used, since it would affect the migration of calmodulin.  The 






Fig. 3.14.  16% SDS-PAGE profile of Nav1.6IQ: Ca2+/CaM crystals.  The uncrystallised complex was included in 




























































Fig. 3.15.  Diffraction image of Nav1.6IQ: Ca2+/CaM crystal.  The crystal diffracted to a resolution of 3.3Å.  Data 
was collected using Platinum135 CCD detector mounted on a Microstar-H rotating anode generator (Bruker, DE) 
given a 20s exposure. 
 
 
 The crystals are currently being optimised to collect complete datasets.  
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3.4 Discussion  
Most of the IQ motifs crystallised with Ca2+/CaM to date belong to the VGCC isoforms.  
Athough the importance of calcium regulation as a feedback mechanism in VGCC is clear; it is 
less obvious why Ca2+ should play a part in the sodium current of the action potential.  The 
importance of Ca2+ regulation, underscored by the fact that all VGSC isoforms possess IQ 
motifs, is ironic because only certain isoforms exhibit strong affinity for CaM (Herzog et al., 
2002).  Each VGSC isoform also has their activity differently regulated by CaM although 
sharing sequence similarity to a large extent (Herzog et al., 2003).  In this study on two IQ 
domains sharing high sequence identity, namely skeletal muscle VGSC isoform Nav1.4 and 
neuronal VGSC isoform Nav1.6 (percentage identity and similarity between IQ motifs of the two 
isoforms is 54% and 80% respectively), we aimed to uncover, if any, (1) the fundamental 
binding mechanism by which VGSC IQ motifs bind to CaM but retain flexibility to interact in 
different ways, and (2) whether the differences in binding affinities between isoforms represents 
the need for Ca2+ recognition during the action potential. 
 The ability of IQ motifs to bind CaM in several ways suggests that each protein recruits 
and utilizes CaM in a unique way.  This is exemplified by the difference in binding dynamics 
between Nav1.4IQ and Nav1.6IQ.  Alignment of Nav1.4IQ, Nav1.6IQ and the IQ motif 
consensus sequences indicate that amino acids differences between isoforms may be responsible 
for differences in the binding modes (Fig. 3.16).  Unlike Nav1.6 that possesses all the conserved 
residues of the IQ motif, Nav1.4IQ does not possess a moderately conserved Gly residue in 
seventh position, or the highly conserved Arg/Lys residue at 11th position.  Non conserved 




Fig. 3.16.  Sequence alignment of previously identified VGSC isoforms Nav1.4 and Nav1.6 IQ motifs. Coloured 
residues refer to the conserved residues in the sequence; residues coloured red are strictly conserved across IQ 
motifs, the moderately conserved G at seventh position is coloured green, while blue residues are those that are 
conserved between Nav1.4 and Nav1.6 isoforms but not part of an IQ motif’s identity. 
   
From the inferred model, the aliphatic part of the side chain of Arg/Lys11 is important for 
forming extensive hydrophobic interactions with CaM.  However, the similar aliphatic part of 
Glu11 side chain in Nav1.4IQ does not engage with CaM and is not involved in stabilising the C-
terminal part of the IQ motif.  The conserved Gly7 is a surface expose residue in Nav1.6IQ.  The 
equivalent residue in Nav1.4IQ is Arg7 which folds back to occlude a part of the CaM surface 
which is exposed in the presence of Gly7 instead.  The residues of Nav1.6IQ fits more 
comfortably into the Ca2+/CaM surface compared with Nav1.4IQ (Fig. 3.17). All of the above 
observations may have contributed to maintaining a stable Nav1.4IQ:apo/CaM complex in the 
absence of NaCl, and also to the unsaturated binding of Nav1.4IQ:Ca2+/CaM as discussed in the 




Fig.  3.17. Superimposition of the modelled Nav1.4IQ (green) and Nav1.6IQ (cyan) peptides on to CaM surface 
(grey).  The C-terminal of Nav1.4IQ protrudes from the CaM surface to a greater extent than Nav1.6IQ, as shown by 
the predominance of green surfaces. 
 
IQ motifs that lack a conserved basic residue in the 11th position have been reported to 
require Ca2+ for binding (Houdusse and Cohen, 1995; Munshi et al., 1996). This conserved basic 
residue is present in Nav1.6 but absent in Nav1.4.  Indeed in conditions without NaCl, apoCaM 
and Ca2+/CaM was observed to have identical affinity for Nav1.6 but the binding of Nav1.4 was 
drastically different in apoCaM and Ca2+/CaM.  These differences may be due to the ability of 
Nav1.6, but not Nav1.4, to stabilise itself on the CaM surface through hydrophobic interaction as 
described above (Fig. 3.17).  However, the molecular details of these interactions can only be 
fully understood from crystal structures of these complexes. 
Although both isoforms share a high sequence similarity in the IQ motif, these results 
indicate a hypersensitivity of CaM towards residue differences in the IQ motif of the two 
IQ motif C-terminal 
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isoforms which may explain why and how highly similar sequences’ binding and regulation by 
CaM are different.  Of course, the influence of residues flanking the IQ motif in CaM interaction 
cannot be ruled out.   
We propose that in tissues where other CaM target proteins are located e.g. in the brain, 
there is competitive sequestration of CaM.  Proteins that require calcium regulation in certain 
states increase their affinities over others for CaM momentarily until a time when a signal has 
passed, such as the increase in affinity of the VGSCs for CaM in the presence of Ca2+.  However, 
proteins that constitutively require CaM for function bind regardless of the Ca2+ concentration.  
High affinity VGSCs, such as Nav1.4 and Nav1.6 may represent a class of ion channels that 
require a Ca2+ sensor at basal level in resting state, but increasing Ca2+ causes a positive feedback 
that increases channel sensitivity for calcium through the increased sequestration of CaM.  These 



























A recurring and fundamentally important theme in the study of signal transduction 
pathways is protein-protein interactions.   Many diseased states are caused by deregulation of 
signalling pathways as a result of abnormal interaction and activating or inhibiting mutations in 
the core components of these pathways.  In order to understand the essential mechanisms 
through which regulatory proteins perform their function, two examples of receptor protein 
regulators from the ERK/MAPK pathway were chosen – c-Cbl and CaM with their respective 
substrates of tyrosine kinases and VGSCs. 
In this thesis, the binding dynamics of both systems were thoroughly described.  In the 
case of c-Cbl, five crystal structures of Cbl-TKB complexed with the different tyrosine kinase 
substrates and another regulator of the ERK/MAPK pathway, Spry2, has illustrated the mode of 
the binding with the TKB domain.  The Cbl-TKB: Met structure also represents the highest 
resolution Cbl atomic model to date.  Elucidation of the Cbl-TKB complex structures has 
unexpectedly revealed the presence of an essential intrapeptidyl H-bond between pTyr and its 
neighbouring residue which binds to Cbl-TKB regardless of the orientation of the sequence. 
 The reverse binding mode of Met, together with its ability to bind to Cbl-TKB when the 
DpYR motif was reversed, suggests the likelihood of other Cbl targets yet to be discovered.  
Although not all potential targets are in vivo binders due to localization, temporal and steric 
factors, it is worth screening for such interactors on a proteomic scale, possibly through the use 
of microarray technology. 
 In depth understanding of the importance of substrate orientation in the context of Cbl 
role in signal transduction would require that structural characterization of Cbl-substrate 
complexes extend beyond peptides.  Proteins harbouring the DpYR motif with a (pY-4)Pro can 
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be interesting candidates for future study, together with proteins whose regulation by Cbl is 
already established, such as EGFR and APS.  Taken together, results from these analyses would 
greatly enhance the understanding of Cbl’s mode of action as an adaptor or as a ubiquitin ligase 
– two distinctly different functions. 
Biophysical and computational modelling data has provided interesting insights towards 
understanding how CaM regulates the VGSCs.  However, the necessity of further work is duly 
acknowledged.  The ITC results obtained may only be explained with a comparative study of the 
real molecular structures of both isoforms in complex with CaM at atomic resolution, an aim that 
we hope to achieve through X-ray crystallography.  However, difficulty in producing diffraction 
quality single crystals even after extensive optimisation is the bottleneck.  Nav1.4IQ: CaM 
would not diffract and the data collected from the Nav1.6IQ:CaM is not complete.  
Improving current crystal quality is the first priority for the CaM: VGSC complexes 
project.  As a final resort, nuclear magnetic resonance spectroscopy (NMR) will also be 
employed to determine the complex structures.   
Two major questions were posed at the outset of this study – (1) What is the fundamental 
mechanism governing VGSC: CaM interaction, and (2) why do certain VGSCs require tight 
binding to CaM but not others.  The first question may be ascertained once complex structures 
are known. Mutation of key residues in the full length receptor to examine its interaction with 
CaM may extend and confirm conclusions drawn from structural studies on the shorter IQ motif 
peptides.  Given the present limited data, a reason to the second question may only be speculated 
from ITC observations.  Resolving the second question requires the full understanding of the 
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CaM signalosome in different VGSC expressing tissues which may be feasible only through the 
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